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Adult stem cells maintain tissue homeostasis and act in response to challenges such 
as infection or mechanical damage. The fruit fly Drosophila melanogaster has emerged as a 
powerful model to study adult stem cells due to its conserved pathways and the existence of 
different stem cell systems, particularly a stem cell niche in the intestine. Intestinal stem 
cells (ISCs) have a major role in maintaining tissue homeostasis and improvements in their 
function result in refined tissue function in aged or damaged organs.  Metabolism plays an 
important role in regulating stem cell activity, influencing cellular events such as 
differentiation and proliferation. However, several aspects remain unraveled, particularly the 
role of different subunits of the mitochondrial electron transport chain (ETC) — end players 
in the oxidative phosphorylation process.  
Given the importance of metabolism in regulating stem cell activity, we hypothesized 
that ETC subunits also have a role in regulating ISC activity and tissue homeostasis. To test 
our hypothesis, we performed a candidate screen to knock down individual subunits of the 
ETC specifically in ISCs and their direct progeny — enteroblasts — in the adult fly and studied 
their requirements for normal cell division, differentiation, survival and impact in 
surrounding differentiated cells. Subunits of the ETC complex II, which converts succinate to 
fumarate in the Krebs cycle, particularly subunit D (SdhD), emerged from the screen as 
strong candidates required for normal ISC activity.  
Knockdown of SdhD in ISCs resulted in inhibition of cell division, hypertrophy with 
polyploidy, and ultimately, cell death. At a tissue level, evidence of a differentiation bias 
towards secretory enteroendocrine cells in lieu of absorptive enterocytes was observed 
upon SdhD knockdown in progenitor cells. Further experiments showed that knockdown of 
SdhD causes succinate to accumulate, possibly due to a decrease in the function of succinate 
dehydrogenase activity. Succinate is a known ligand for the GPR91 receptor in mammals 
which is known to be involved in cellular hypertrophy and death via apoptosis. Further 
studies need to be performed to determine the existence of a succinate receptor in 
Drosophila.  
This work has unveiled a direct relationship between inhibition of complex II subunits 
and stem cell hypertrophy and death, with succinate as a possible intermediate, and 
provides a suitable model for the study of the molecular pathways underlying cellular 
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hypertrophy and death in metabolic-deficiency backgrounds. These insights may contribute 
to the understanding of hypertrophic pathologies, or proliferative diseases, such as cancer. 
Keywords: stem cells, intestine, metabolism, hypertrophy, cell division, cellular death, 
homeostasis 
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As células estaminais existem em organismos adultos onde possuem um importante 
papel na manutenção da homeostase e na resposta a danos no tecido. A mosca-da-fruta 
Drosophila melanogaster destaca-se como um modelo animal no estudo de células 
estaminais, graças aos seus diferentes mecanismos moleculares conservados entre espécies 
e à presença de células estaminais adultas, nomeadamente de um nicho de células 
estaminais no intestino. As células estaminais intestinais (ISCs, na sigla inglesa) 
desempenham um papel crucial na regulação da homeostase no tecido, e vários estudos 
demonstram que melhorias na sua função celular resultam em melhorias na capacidade dos 
tecidos num contexto de envelhecimento ou detioração de tecidos. O metabolismo 
desempenha um papel crucial na regulação do comportamento e actividade de células 
estaminais através de moléculas metabólicas intermediárias e produtos de reacção, que 
controlam como estas se diferenciam ou dividem. No entanto, ainda existem vários aspectos 
a serem estudados, nomeadamente o papel de diferentes subunidades dos complexos da 
cadeia de respiração mitocondrial (ETC, na sigla inglesa). 
Dada a importância do metabolismo na regulação da actividade de células 
estaminais, levantámos a hipótese de que subunidades da ETC desempenham um papel na 
regulação do comportamento das ISCs, com um impacto na homeostase no tecido. Para 
testar esta hipótese, induzimos subexpressão de diferentes subunidades da ETC em células 
progenitoras no intestino (incluindo ISCs) por vias de interferência de RNA, e avaliámos os 
efeitos no comportamento de células progenitoras e o consequente papel no tecido 
intestinal. Subunidades do complexo II, nomeadamente a succinato dehidrogenase, 
subunidade D (SdhD) destacou-se entre as várias, por ser requerida em ISCs. 
Subexpressão de SdhD inibe a replicação de células estaminais, induz poliploidia, 
hipertrofia e por fim, morte celular.  A nível de impacto no tecido intestinal, as células 
progenitoras sofrem uma mudança de comportamento, notando-se uma preferência na 
diferenciação em células enteroendócrinas em vez de enterócitos.  
Análises quantitativas indicaram que subexpressão da SdhD causa uma acumulação 
de succinato no tecido.  O succinato é um activador conhecido do receptor acoplado à 
proteína G 91 (GPR91), que foi em estudos prévios associado a hipertrofia e apoptose.  
Os resultados obtidos neste trabalho contribuíram para um melhor entendimento 
relativamente aos mecanismos de regulação da actividade celular por processos 
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metabólicos, demonstrando que a Drosophila melanogaster é um modelo importante para o 
seu estudo. Uma melhor compreensão acerca dos processos de regulação de hipertrofia e 
replicação celular poderá ter um impacto positivo no desenvolvimento de terapias para 
doenças relacionadas com hipertrofia, ou com replicação celular, como o cancro.  
Termos chave: células estaminais intestinais, metabolismo, hipertrofia, morte celular, 
divisão celular, homeostase
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Introductory remarks 
In part 1 of his chapter, I introduce the different types of stem cells and their role in 
development and tissue maintenance. In the second part, I describe the intestine of the 
fruit-fly Drosophila melanogaster as an adult stem cell niche model and the conserved 
mechanisms that regulate homeostasis and stress responses. In part 3, I present the basis of 
metabolic regulation of stem cells, explore the existing gaps in the field, and describe the 
workplan to answer some of the pending questions. 
1- Stem cells: role in development and tissue repair 
Stem cells are characterized by their ability to divide through mitosis to produce 
more stem cells (self-renewal) and differentiate to a specific cell lineage. These traits allow 
them to build new tissue and organs during development where a great number of new cells 
is required, and to provide tissue homeostasis or regeneration during adulthood [1][2].  
Stem cells are divided into three main categories: embryonic stem cells (ESCs), adult 
stem cells (ASCs; also referred to as somatic stem cells), and induced pluripotent stem cells 
(iPSCs). Early embryonic stem cells in the morula are totipotent, as they can give rise to all 
cell types in the body, including the extraembryonic, or placental cells. Upon formation of 
the blastocyst, the inner mass cells are considered to be pluripotent, as they generate the 3 
types of embryonic germ layers: ectoderm, mesoderm and endoderm. During development, 
these cells become more restricted in their ability to differentiate into multiple lineages. In 
adults, where stem cells are only capable of forming a limited number of cell types, they are 
considered to be multipotent or unipotent [3][4][5]. ASCs are found in different tissues of 
adult organisms across species. The most studied in mammals are hematopoietic stem cells 
(HSCs) and mesenchymal stem cells (MSCs), which have a lower self-renewal potential than 
ESCs [6]. Germline stem cells are usually considered to be ASCs. The third category of stem 
cells, iPSCs, is obtained from mature adult cells, normally fibroblasts, that were artificially 
reprogrammed in vitro to an ESC-like state mainly through overexpression of core stemness 
regulators [7], which are detailed below.  
Embryonic stem cells 
ESCs were first isolated in 1981 from the inner cell mass of early embryos and 
blastocysts of mice [8][9]. These cells have the ability to proliferate indefinitely in vitro while 
remaining pluripotent, rapid proliferation and high telomerase activity [10]. These cells can 
be differentiated in vitro into a variety of specific cell types such as neural [11], cardiac [12] 
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or intestinal lineages [13]. As such, ESCs have a high therapeutic potential to repopulate and 
repair damaged or degenerating tissues.  
Induced pluripotent stem cells 
iPSCs are generated from differentiated cells by expressing core transcription factors 
that are required for maintenance of pluripotency and proliferation of ESCs. In their 2006 
groundbreaking study, Yamanaka and colleagues reprogrammed murine fibroblasts to iPSCs 
by retroviral-mediated expression of the ‘stemness’-associated factors OCT4 (octamer-
binding transcription factor 4), SOX2 (SRY (sex-determining region Y)-box 2), KLF4 (Kruppel-
like factor 4), and C-MYC [14]. In 2007, Yu and colleagues generated mice iPSCs by expressing 
a different set of factors, OCT4, SOX2, NANOG, and LIN28, using a lentiviral system [15]. 
Following these accomplishments, researchers were also able to generate iPSCs derived from 
human somatic cells [16]. iPSCs exhibit many traits similar to ESCs, such as morphology, cell-
surface markers, telomerase activity and epigenetic marks, but they differ in global gene 
expression [7].  
Adult stem cells 
Most adult tissues contain reservoirs of stem cells used to replenish differentiated 
cells that are lost upon tissue injury, infection or normal cell turnover. Upon stress, 
differentiated cells send a variety of signals to stem cells to regulate their replication and 
differentiation dynamics [2][17]. In some organisms, upon injury, fully differentiated cells 
can also de-differentiate to stem cells in order to fulfill the requirements of stem cell 
population to provide the tissue with newly formed cells [1].  In the absence of injury, ACSs 
continue to generate new cells to replace those that have worn out, in order to maintain 
tissue homeostasis. While many of the pathways responsible for ASC activation are shared 
with those in pluripotent stem cells during development, the dynamics of cell 
communication and proliferation are distinct, as are the types of cells involved. Studies in 
mice and humans have shown the existence of different ASC types across the organism, 
including in the bone marrow [18], skeletal muscle [19], skin epithelia [20], intestine [21], 
heart [22][23], brain [24][25], and lungs [6][26].  These cells are used sparingly and are 
generally tucked away in protected niches [6]. They are also scarce, and with the relative 
exception of HSCs, are difficult to isolate. 
HSCs produce all the different cells present in the mammalian blood, including 
platelets, red blood cells and white blood cells. These cells and their progenitors can be 
collected from umbilical cord blood or peripheral blood, and isolated by their cell-surface 
markers such as CD34. In contrast, MSCs generate various mesodermal cell lineages, 
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including myocytes, chondroblasts, fibroblasts, osteoblasts and adipocytes. MSCs are usually 
isolated from bone marrow and umbilical cord blood and display a different expression 
profile of cell surface markers than that of HSCs [7].  
The stem cell nice 
ASCs are often tucked away in niches, physically protected from potential damage, 
either mechanical or from pathogens. The stem cell niche also comprises a pool of intricate 
signals occurring between the stem cells and their environment, that are required for proper 
tissue homeostasis and response to damage. In the niche, ASCs are largely quiescent, i.e., 
they display low proliferation and differentiation rates. The germline of Drosophila was one 
of the first stem cell niches to be characterized [27]. In mammals, the bone marrow is an 
example of a niche, where HSCs reside [6]. The concept of the niche is better perceived in 
part 2 of this chapter in the context of the Drosophila intestinal epithelium. 
Applications 
Due to their potential to self-renew, possibility of in vivo growth and patient 
specificity, stem cells have a notable potential for regenerative medicine. Animal models and 
clinical studies have shown that transplantation of stem cells from diverse origins can 
successfully treat many acute and chronic diseases. Bone marrow transplantation is the most 
common example, used to treat aplastic anemia, leukemias, immune deficiency and 
hemoglobin disorders. The potential for stem cell therapy extends to many disorders, 
including myocardial infarction, Parkinson disease, myelin disease and liver failure [6][28]. 
iPSCs present a high potential for transplantation treatments as they have the same genetic 
signature as other cells in the patient, greatly reducing chances of immune rejections, and 
can be genetically corrected [16].  
To fully explore the therapeutic potential of stem cells it is essential to understand 
the mechanisms that regulate their activity.  Dissecting the mechanisms of proliferation is 
also of great importance for the development of targeted therapies against tumor 
progression, as cancer cells share many common replication pathways with stem cells 
[29][30]. The mechanisms responsible for stem cell division and differentiation are largely 
conserved among species, and as such, several animal models are used to study stem cell-
mediated development, regeneration and homeostasis, as described below. 
Non-mammalian models of development and regeneration 
Stem cell research is not limited to mice and humans, and several other animals such 
as the chick, amphibians, fish or the fruit-fly have provided the community with important 
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insights about morphological patterning during development and stem cell activation in 
adults. Amphibians such as urodeles (salamanders or axolotls) or anurans (frogs or toads) 
have high regeneration potential and have been studied as models for limb repair. As 
tadpoles, anurans are able to regenerate limbs and tails but this capacity to regenerate 
rapidly declines during metamorphosis [5]. Zebrafish has emerged as a powerful model 
organism to study vertebrate development and regeneration [17][31]. Zebrafish is able to 
regenerate retina, heart and the fin, which has been extensively used a model for 
regeneration. ASCs have also been characterized in the intestine and bone marrow. 
Regeneration in zebrafish may rely on stem cell activation, or dedifferentiation of 
surrounding cells. Zebrafish offers several advantages such a short generation time, live 
imaging and fast regeneration of the caudal fin upon amputation [5][31]. The chicken 
embryo, possibly the oldest system used to study vertebrate development — dating back to 
Aristotle around the year 350 BCE — has contributed substantially to the understanding of 
human development and disease [32]. The chicken embryo is an attractive model due to 
being phylogenetically closer to mammals than zebrafish, having a convenient size, being 
stationary, having a short incubation time, and the egg being nutritionally self-sufficient 
[33][34]. 
The fruit-fly Drosophila melanogaster as a model for adult stem cells 
The fruit-fly Drosophila melanogaster has been extensively used as a model to study 
development and ASCs [27]. It offers several advantages such as having a fully-sequenced 
genome, short reproductive cycle, relatively low maintenance and large availability of 
genetic tools such as collections of transgenes and mutated alleles, drivers (promoters) of 
gene expression that cell type — and temporal — specific, RNAi-interference (RNAi) 
constructs, and different types of fluorescent reporters [35]. Furthermore, Drosophila shares 
several conserved pathways with humans, including those involved in metabolism and also 
regulation of stem cells [36].  
The adult intestine of the fruit-fly Drosophila melanogaster contains  a stem cell niche 
and has emerged as an important model in the study of ASCs, allowing for a better 
understanding of regulatory mechanisms both during homeostatic and stress-response 
conditions [37][38][39][40]. The following section explores the intestinal stem cell niche of 
the fruit fly, comparing differences to the mammalian intestine and the several conserved 
pathways responsible for regulation of stem cells. 
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2- The intestine of Drosophila melanogaster  
The intestine absorbs ingested water and food and provides a barrier against harmful 
agents, such as bacteria and toxins from the environment. To maintain these roles, it must 
be  highly adaptive in response to both environmental cues and intrinsic signals.  
Morphology 
The intestine of Drosophila comprises three main morphologically distinct sections: 
the foregut, the midgut, and the hindgut [41]. The foregut is located at the most anterior 
part of the intestine and stores food and regulates its flow into the midgut for further 
processing. The midgut, of endodermal origin, corresponds to the small intestine in humans 
and is responsible for food digestion and nutrient absorption. In similarity with the 
mammalian small intestine, the midgut is highly compartmentalized and can be divided 
according to differences in gene expression, pH, metabolism, enzymes and immunity. It is 
surrounded by a network of tubules known as trachea that deliver oxygen to its cells and by 
longitudinal and circular muscle that mediate intestinal peristalsis. The midgut comprises a 
simple linear epithelium, in contrast to the small intestine of mammals that contains several 
invaginations named Crypts of Lieberkühn, that harbor stem cells at its bottom part. The 
hindgut, of ectodermal origin, is located at the posterior-most part of the intestine and 
corresponds to the large intestine in humans [41][42]. The focus of this work is on the 
midgut part of the intestine, where a stem cell nice exists and has been used as a model to 
dissect pathways involved in somatic stem cell behavior [37][38][39][40].  
Composition 
The midgut of Drosophila is composed of several absorptive enterocytes (ECs), which 
are terminally-differentiated, large polyploid cells. ECs contain a brush border consisting of 
microvilli on its apical side (depicted in Figure 1 A, in blue), that increase its surface area to 
aid nutrient absorption, in similarity with mammalian ECs [41]. Enteroendocrine cells (EEs), 
present in both Drosophila and mammalian intestine, are fully differentiated diploid cells 
that are responsible for segregating regulatory peptides. These peptide hormones are 
responsible for regulation of appetite, gastrointestinal motility and secretion, and have 
sequence and functional homology to the ones in mammals [42][43]. EEs express the 
homeodomain transcription factor Prospero (Pros) and are uniquely identified using anti-
Prospero antibodies in immunofluorescent imaging. The tubular epithelium is surrounded by 
thebasal membrane (BM)  --  an extracellular collagenous matrix that is also present in 
mammals. Visceral muscle layers (VM) reside underneath the BM [40]. 
9 
 
 Intestinal stem cells (ISCs; Figure 1 A, in green) are responsible for generation of new 
cells in the midgut. These diploid cells reside near the BM and commonly form pairs with 
their daughter cells, the enteroblasts (EBs; in cyan) which express the transcription factor 
Suppressor of hairless (Su(H)) [37][38]. ISCs and EBs are collectively referred to as 
“progenitor cells”. ISCs are tucked away in their niche, where they are separated from the 
lumen where potential damaging factors exist. At this location, ISCs receive signals both from 
muscle cells below and from the other cell types around. 
The mammalian small intestine, in contrast to the linear epithelium of the Drosophila 
midgut, has several epithelial protrusions called villi that greatly increase its absorptive 
surface area. These are maintained by stem cells identified by their cell-surface markers 
Bmi1 (B lymphoma Mo-MLV insertion region 1 homolog) and Lgr5 (Leucine-rich repeat-
containing G-protein coupled receptor 5) [41]. 
Homeostasis/differentiation 
To maintain homeostasis upon loss of differentiated cells due to injury or normal cell 
turnover, ISCs divide to replenish tissue. ISCs can divide symmetrically to proliferate, 
generating a new identical ISC, or asymmetrically to generate an ISC and a newly formed EB. 
EBs are transient cells that do not divide, and eventually differentiate to either ECs or EEs 
[41]. EBs are formed as small, diploid cells and while differentiating into ECs may go through 
endoreduplication and appear larger [44]. 
The Notch pathway is a major regulator of progenitor cell maintenance and 
differentiation in different organisms and systems, including the fly and mammalian 
intestines. In Drosophila, ISCs express the Delta ligand which binds the cell-surface Notch 
receptor in EBs and activates the Su(H) factor that identifies them in the midgut (Figure 1 B). 
Both progenitor cell types express the transcription factor Escargot (Esg), a homologue of the 
mammalian Snail family, that acts as an inhibitor of differentiation [45]. The differentiation 
choice to either ECs or EEs is controlled by the intensity of Delta-Notch signaling between 
ISCs and EBs: higher levels of Notch signaling lead EBs to differentiate into ECs, while lower 
Notch activity causes them to differentiate into EEs [45]. It has also been observed the 
existence of a subset of ISCs that accumulate Pros in a polar manner inside the cell and, upon 
division, Pros remains in one of the new cells that will become an EE [42][46].  
Notch genes encode transmembrane receptors that regulate a broad spectrum of cell 
fate decisions and differentiation processes during development. Binding of one of the four 
Notch receptors with Notch ligands (Delta or Serrate in Drosophila) results in proteolytic 
cleavage of the receptor, releasing the free Notch intracellular domain (Nintra) that 
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translocates into the nucleus, where it binds to different transcription factors  (including 
Su(H) (the homologue of mammalian CBF1) to activate the expression of target genes 
[47][48][49]. In the mammalian intestine, Notch is essential to maintain the stem cell crypt 
compartment in its undifferentiated, proliferative state and also controls absorptive versus 
secretory fate decisions. In Drosophila, Delta–Notch signaling also promotes the mitotic-to-
endocycle switch during differentiation to ECs [50].  In EBs, Esg positively regulates Notch 
activity via its target Amun. Notch-RNAi in progenitor cells causes Esg-positive tumors and 
elevated numbers of EEs [45]. Loss of Notch function within ISCs may block differentiation in 
EBs, leading to over-proliferation of ISCs [38].  In contrast to the mammalian intestine, where 
Notch favors proliferation of stem cells, in Drosophila is required for differentiation. 
However, in both Drosophila and mammals, Notch activation favors differentiation towards 
an enterocyte fate at the expense of secretory cells [40][51]. 
In the mammalian intestine, Bmi1+ stem cells divide asymmetrically to generate one 
cell of the same type and a new Lgr5+ stem cell, which in turn divides asymmetrically to yield 
one cell of the same type and a transient amplifying (TA) cell that divides a limited number of 
times and finally differentiates into one of the 4 fully-differentiated cell types: enterocytes, 
enteroendocrine cells, Paneth cells, or mucous-secreting goblet cells. The intestinal crypts 
harbor stem cells and TA cells. TA cells divide 4–5 times before they terminally differentiate 
into the specialized intestinal epithelial cell types, that then localize to the tip of the villus, 
with the exception of the Paneth cells that remain at the bottom of the crypts. When the 
cells at the tip of the villi undergo apoptosis, they are shed into the lumen. Paneth cells are 
responsible for innate immunity and antibacterial responses, as they secrete bactericidal 
peptides and lysozymes [47]. In analogy to Esg expression in progenitor cells of flies, 
expression of Snai1—a member of the mammalian Snail family—was found in ISCs and TA 
cells of mice [52].  
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Figure 1: Stem cell niche morphology and cell lineage specification in the midgut of Drosophila melanogaster 
A. Cross-sectional representation of the cellular organization in the mono-layered intestinal epithelium of 
Drosophila. Intestinal stem cells (ISCs, in green) are located near the basal membrane (BM) and do not share an 
interface with the lumen. Enteroblasts (EBs, in cyan) are transitory daughter cells of ISCs that differentiate into 
the other cell types. EBs may assume different shapes and sizes while differentiating. Enteroendocrine cells 
(EEs, in red) are small diploid cells that segregate peptides and hormones to aid digestion. Enterocytes (ECs) are 
large polyploid cells responsible for nutrient absorption that have microvilli to increase the area of contact with 
the lumen. All cells lay on the BM that is surrounded by visceral muscle (VM) that regulates the movement of 
food. Image adapted from Dutta et al [53]. B. Lineage specification in the midgut. ISCs divide either 
asymmetrically to originate a new ISC and a daughter EB, or symmetrically to generate two identical ISCs. ISCs 
express Delta, which binds the Notch receptors in EBs (in orange), and activates the Suppressor of hairless 
(Su(H)) transcription factor in these cells.  ISCs and EBs are commonly found in pairs and are collectively 
referred to as progenitor cells. They both express the transcription factor Escargot (Esg, in green). EBs 
differentiate into either ECs or EEs depending on the intensity of the Delta-Notch (N) signaling originating from 
the ISC-EB interface: higher levels of Notch signaling cause EBs to differentiate to ECs, while low Notch signaling 
promotes differentiation to EEs.  The fluorescent stain DAPI marks the nuclei of all cells, which are considerably 
larger in ECs (in blue). EEs are marked by expression of the transcription factor Prospero (Pros). Image obtained 
from Loza-Coll et al. [45]. 
 
Aging in the intestine of Drosophila melanogaster 
During aging, there is a loss of tissue homeostasis, causing ISCs to divide more often, 
and a widespread accumulation of cells that express both markers of progenitor (Esg+) and 
differentiated cells, suggesting a compromised ability for terminal differentiation. These cells 
form stacks of double and triple layers as opposed to the single layer found in healthy 
intestines and show reduced barrier permeability [54][55][56]. Examples of these intestines 
are found later in sections 1.1 and 2.2 of the Results and Discussion chapter.  
Mechanisms of stem cell modulation 
Cells in the intestine are constantly challenged by exposure to bacteria and other 
damaging factors. Exposure to stressors such as potent oxidants such as hydrogen peroxide 
or paraquat, or bleomycin—a DNA-damaging peptide that induces strand breaks—triggers 
intestinal stem cell proliferation in response to enterocyte death [42][57]. Upon sensing 
damage, these cells initiate a series of signals to stimulate ISC division and EB differentiation 
in order to restore tissue structure and function. When severely damaged, ECs enter an 
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apoptotic program and are excised to the lumen, in similarity with the mammalian case. The 
rates of progenitor cell division and differentiation are adjusted in response to EC and EE 
turnover through a combination of positive and negative feedback loops initiated by these 
cells [42]. Several conserved pathways are involved in autocrine or paracrine signaling 
occurring between progenitor and differentiated cells in the niche, which are described 
below. 
JAK/STAT (Janus kinase/signal transducers and activators of transcription) is a 
pathway  activated by a variety of ligands that is involved in proliferation, differentiation and 
apoptosis, during development, homeostasis or stress-responses. In the midgut of 
Drosophila, Jak-Stat is activated by the cytokines of the Unpaired family Upd, Upd2 and 
Upd3. Upon stress, ECs release these cytokines to promote ISC proliferation and  EB 
differentiation, via stimulation of Delta-Notch signaling [58]. Unpaired ligands bind the 
Domeless receptor, phosphorylating Hopscotch, a type of Janus kinase, promoting 
translocation of the Stat92E transcription factor to the nucleus, to activate its target genes 
[59]. In the mammalian intestine JAK-STAT plays a similar role [58].   
Wnt signaling (Wingless, or Wg, in Drosophila) is a conserved pathway that plays key 
roles both during development and in maintenance of different adult tissues [60]. 
Endogenous Wg ligands are expressed at low levels in ISCs of Drosophila and act to promote 
self-renewal in these cells [61]. Wg is also expressed in the visceral muscle [61] and EBs upon 
injury [62] to promote ISC division. Conversely, Wg signaling from the visceral muscle inhibits 
Upd2 and Upd3 expression in ECs suppressing ISC activity via inhibition of the JAK-STAT 
pathway, suggesting a dual role part of a tightly regulated network [63]. In the mammalian 
small intestine, Wnt is expressed in the crypt to promote stem cell renewal and control 
differentiation [64]. Wnt/Wg signaling works by binding of the Wnt/Wg ligand to its 
coreceptors, Frizzled2 and LRP (Arrow in Drosophila), to initiate a sequence of events that 
leads to Dishevelled–mediated inactivation of a protein destruction complex that allows 
stabilized β-catenin (Armadillo in Drosophila) to translocate to the nucleus, binding to the 
transcription factor T-cell factor that promotes the activation or repression of genes related 
to proliferation, apoptosis and cell fate [65][60]. Notch also acts downstream of the Wg 
pathway to control maintenance and differentiation of Drosophila intestinal progenitor cells 
[61]. 
JNKs (c-Jun N-terminal kinases) are part of a conserved mitogen-activated protein 
kinase (MAPK) cascade with important roles in development, wound healing, and stress-
responses [66][67][68]. In Drosophila, the JNK Basket (Bsk) is phosphorylated by the JNK 
kinase (JNKK) Hemipterous (Hep). Bsk then phosphorylates different transcription factors, 
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including Foxo (Forkhead Box O transcription factor), inducing changes in gene expression 
related to growth, proliferation and differentiation. Upon stress, JNK mediates the 
transcription of damage-repair genes such as thor and small heat shock proteins. In the 
midgut, JNK is activated in ECs and EEs. ECs with dysfunctional tricellular junctions signal to 
ISCs to promote proliferation and regeneration [69]. JNK pathways have a dual-role in 
promoting apoptosis or inducing stem cell proliferation, depending on the type of activated 
transcription factors [54]. JNKs are also present in the mammalian intestine, where it 
modulates Wnt signaling [68][41][67]. 
The epidermal growth factor receptor (EGFR) is activated by ligands produced in the 
intestinal epithelium upon damage or stress, promoting ISC proliferation. The EGFR ligand 
Vein is expressed in the visceral muscle to promote ISC maintenance and proliferation. ISCs 
also express two different EGFR ligands, Spitz and Keren, that act as autocrine signals to 
maintain these cells [70]. Upon damage, the EGFR receptor induces activation of the RAS 
GTPase and MAPK, which phosphorylates the transcriptional repressor Cic (Capicua), 
activating expression of cell cycle regulator genes Pointed, Ets21C, Cdc25 and cycE (Cyclin E) 
[71]. Mammal ISCs also require EGFR signaling for proper function [41]. 
IGF (insulin-like growth factor; InR in Drosophila) signaling is a conserved pathway 
involved in cell growth and proliferation. In the Drosophila midgut, muscle cells and EBs 
express insulin-like peptides named Dilps that induce ISC proliferation [72]. Dilps activate InR 
that signals through Chico, a homolog of the mammalian insulin receptor substrates 1–4 (IRS 
1–4), activating PI3K (phosphatidylinositol 3′-kinase), leading to phosphorylation of Akt 
(protein kinase B), which inhibits the transcription factor Foxo and activates TOR (target of 
rapamycin) protein kinases, that promote growth and proliferation [73][74]. Insulin signaling 
may also stimulate cell proliferation via activation of the RAS/MAPK pathway [75]. 
Hedgehog (Hh) signaling is another conserved pathway involved in cell growth and 
proliferation. In the midgut of Drosophila Hh is activated in injured EBs and promotes the 
expression of Upd2 to activate the JAK-STAT pathway that promotes ISC proliferation. Hh is 
also active in the mammalian intestine where it promotes differentiation via inhibition of 
Wnt signaling [76].  
Hippo is a conserved pathway initially identified in Drosophila that controls organ size 
by restraining stem cell proliferation and inducing apoptosis in specific cells. It is a complex 
signaling network with over 30 components. The core of the Hippo pathway is a kinase 
cascade leading from activation of the tumor suppressor Hippo (Mst1/2 in mammals) that 
phosphorylate Warts (Lats1/2 in mammals) to inhibit the activity of the transcriptional co-
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activator Yorkie (YAP and TAZ in mammals). When active, Yorkie translocates to the nucleus 
to bind the transcription factor Scalloped (TEAD family in mammals) to induce expression of 
a wide range of genes involved in autocrine or paracrine cell proliferation and survival 
responses, such as diap1 (Drosophila inhibitor of apoptosis), cycE, Upd1/2/3 and Vein 
[77][78][79]. Stress-induced Hippo pathway inactivation in ECs of Drosophila results in 
increased stem cell proliferation via expression of Upd JAK/STAT ligands. In ISCs, Hippo 
inactivation or Yki overexpression results in increased proliferation [51]. In the mouse 
intestine, overexpression of YAP also leads to activation of progenitor cell proliferation [80] 
The pathways here described act synergistically to maintain homeostasis in the 
Drosophila midgut. As an example, inactivation of either EGFR, Wg or JAK/STAT results in 
progressive ISC loss over time, while simultaneous disruption of these 3 pathways leads to 
total loss of ISCs. However EGFR over-activation can partially replace Wg or JAKSTAT, and 
vice versa [70]. Upon stress, JNK and EGFR signaling act simultaneously to initiate ISC 
proliferation, via activation of Sox21a (a member of the conserved Sox family of transcription 
factors) in these cells [81].  
In summary, the physical location of the different cell types in the intestine and the 
intricate signaling that occurs between them constitute the intestinal stem cell niche. This 
presents a powerful model for the study of stem cells in a tissue context, owing to its 
conserved signaling pathways, availability of genetic tools, and morphological simplicity. The 
following sections explore the importance of metabolism in regulating stem cell activity in 
different systems.  
 
 
 
 
 
 
15 
 
3- Role of metabolism in stem cell activity 
3.1- Energy production in Metazoa  
Metabolism transforms nutrients into usable forms of energy and provides substrates 
for synthesis of new molecules. In the cytoplasm, glucose is broken down into pyruvate via 
glycolysis, reducing nicotinamide adenine dinucleotide (NAD+) to NADH and producing 
adenosine triphosphate (ATP) from adenosine diphosphate (ADP). Pyruvate obtained from 
glycolysis is then transported into the mitochondria via mitochondrial pyruvate carriers 
(MPCs), where it is converted to acetyl-CoA by pyruvate dehydrogenase that enters the Citric 
Acid Cycle (also Krebs Cycle, or TCA (tricarboxylic acid) cycle). Under limiting oxygen 
conditions, pyruvate from glycolysis is instead reduced to lactate by lactate dehydrogenase, 
regenerating NADH back to NAD+ to reenter glycolysis. This fermentation process is less 
efficient than aerobic respiration (described below), as for each molecule of glucose, aerobic 
respiration generates 36 molecules of ATP while anaerobic glycolysis generates only 2 
molecules [82]. This process, however, can produce ATP at a faster rate than aerobic 
respiration [82][83].  
Cells also produce ATP via protein catabolism. In this process, the α-amino group of 
amino acids is removed, and the resulting carbon skeleton is converted into different 
metabolic intermediates depending on the amino acid. These intermediates 
include pyruvate, acetyl-CoA, acetoacetyl-CoA, or the TCA cycle intermediates α-
ketoglutarate, succinyl CoA, fumarate, and oxaloacetate and can be used to form fatty acids, 
ketone bodies, or glucose [86].  Amino acids that are converted to acetyl-CoA or acetoacetyl-
CoA are termed ketogenic amino acids since they can give rise to ketone bodies or fatty 
acids. Amino acids that yield pyruvate, α-ketoglutarate, succinyl CoA, fumarate, or 
oxaloacetate are termed glucogenic amino acids [86][87]. 
Lipids are broke down in the cytoplasm into glycerol and fatty acids in a process 
called lipolysis. Fatty acids are then broke down in the mitochondria in the beta-oxidation 
pathway to generate acetyl-CoA that enters the Krebs cycle, and NADH and FADH2 that are 
used by the electron transport chain (ETC) to generate ATP [88]. Acetyl-CoA is also produced 
by oxidation of fatty acids in the mitochondria via beta-oxidation, yielding NADH and flavin 
adenine dinucleotide in the reduced form (FADH2) [84][85]. 
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In aerobic respiration, acetyl-CoA generated from the different aforementioned 
processes enters the Krebs cycle  in the mitochondrial matrix, where it undergoes several 
transformations to yield NADH and ATP (Figure 2). 
The ETC occurs in the inner mitochondrial membrane and oxidizes NADH and 
succinate from the Krebs cycle, building up a proton gradient across the inner mitochondrial 
membrane, which is ultimately used to generate ATP from ADP (adenosine diphosphate) 
(Figure 2). This highly conserved process is termed oxidative phosphorylation (OXPHOS) [85].    
The ETC comprises 5 complexes. Complexes I - IV are responsible for the transport of 
electrons to the corresponding reducing sites or the transfer of H+ protons across the 
membrane, while complex V (ATP synthase) uses the potential created by the proton 
gradient to generate ATP, channeling H+ back into the mitochondrial matrix. ATP is then 
transported to the cytosol to be used by the cell as energy [85].  
Complex I (NADH:ubiquinone oxidoreductase) is the largest complex in the ETC and  
contains 44 subunits which are encoded by both mitochondrial and nuclear genome [89]. 
These subunits are assembled by 4 assembly factor proteins in humans, and at least 1 in 
Drosophila [90]. Complex I oxidizes NADH from the Krebs cycle to NAD+ with removal of 2 
electrons. These electrons are transported to a ubiquinone (coenzyme Q10, Q, Figure 
2) binding site, where it is reduced to ubiquinol (QH2). The electron flow within the complex 
is thought to cause conformational changes in its proteins, causing them to pump the 
hydrogen protons originating from NADH to the inter-membrane space [91].  
Complex II (succinate dehydrogenase, SDH) participates both in the Krebs cycle and in 
the ETC [85].  It is composed of 4 subunits—SdhA, SdhB, SdhC and SdhD. The subunit A is 
responsible for the enzymatic activity that leads to the conversion of succinate to fumarate 
via reduction of the flavin adenine dinucleotide (FAD) cofactor to FADH2 in the Krebs cycle. 
The remaining subunits—SdhB, SdhC and SdhD—channel the resulting electrons via iron-
sulfur clusters to the ubiquinone binding site, where it is reduced to ubiquinol, as part of the 
ETC. While SdhA and SdhB are lipophobic components, SdhC and SdhD are lipophilic subunits 
that keep the complex attached to the mitochondrial inner membrane [92].  
Complex III (coenzyme Q:cytochrome c – oxidoreductase) is composed of 11 
subunits; it accepts electrons from ubiquinol — which was reduced at complexes I and II — 
and regenerates it back to ubiquinone. The electrons obtained from the oxidation of 
ubiquinol are then transferred to the carrier cytochrome c, in a process that is coupled to the 
pumping of H+ protons from the matrix to the intermembrane space. Complex IV 
(cytochrome c oxidase) is composed of 14 subunits, both nuclear—and mitochondrial—
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encoded. This complex oxidizes cytochrome c (reduced at complex III) and transfers the 
resulting electrons to reduce molecular oxygen (O2) in the mitochondrial matrix, generating 
water. Finally, complex V (ATP synthase) uses the electrochemical potential generated from 
the proton gradient to add an inorganic phosphate group to ADP to form ATP, through a 
rotational motor mechanism. This process requires that protons that built up in the 
intermembrane space are transported back to the matrix, completing the process [85].  
 
  
 
Figure 2: Krebs cycle and the electron transport chain 
The Krebs cycle takes place in the mitochondrial matrix and oxidizes acetyl-CoA in a series of steps to produce 
NADH and FADH2 that are used by the electron transport chain (ETC). The ETC takes place in the inner 
mitochondrial membrane (IMM) and is composed of 5 complexes: complex I oxidizes NADH from the Krebs 
cycle to NAD
+
, coupled to a reduction of ubiquinone (Q) to ubiquinol (QH2); complex II is composed of 4 
subunits (with their protein structure detailed in the picture) and participates in both the Krebs cycle and the 
ETC; it oxidizes succinate to fumarate in the Krebs cycle, and the resulting electrons reduce ubiquinone to 
ubiquinol in the IMM as part of the ETC. Ubiquinol is then oxidized in complex III, which is coupled to a 
reduction of cytochrome c. Cytochrome c is then oxidized in complex IV and the resulting electrons reduce 
molecular oxygen (O2) to water (H2O). Finally, complex V (ATP synthase; not shown) generates ATP using the 
potential from the proton gradient generated across the IMM from the successive oxidations in the previous 
steps, completing the process. Image source: L. Hederstedt [92]. 
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3.2- Metabolic regulation of stem cell activity  
This section covers the differences in mitochondrial dynamics and metabolic 
requirements between stem cells and their differentiated counterparts, describing how 
changes in metabolic pathways may strongly influence stem cell behavior. 
Besides playing a fundamental role in energy production through oxidative 
phosphorylation (OXPHOS) or amino acid or fatty acid catabolism, mitochondria play 
important roles in cell signaling by metabolic intermediates, reactive oxygen species (ROS), 
calcium homeostasis, and apoptosis [93].  
Mitochondria structure in different cell types 
Several studies have established correlations between cell potency (or stemness) and 
the structure of their mitochondria. Electron microscopy studies reveal that while somatic 
cells such as fibroblasts show mature, elongated mitochondria, with numerous cristae and 
an electron-dense matrix, ESCs or iPSCs contained fewer, immature, and globular 
mitochondria. [94][95][96][97]. Accordingly, during differentiation of ESCs and iPSCs,  the 
mitochondria of these cells change to a more mature morphology and replicate to higher 
numbers [95]. These data suggest that stem cells rely less on OXPHOS for obtaining their 
energy. 
Metabolic shifting between stemness states 
In addition to the increase in mitochondrial biogenesis and structural differences, 
studies in different cell populations indicate that while differentiated cells mainly depend on 
OXPHOS as the primary source of energy production, stem cells traditionally rely largely on 
glycolysis as their main source of NADH and ATP. Accordingly, differentiation of ESCs and 
iPSCs is generally associated with a metabolic shift from a predominant glycolysis-based 
metabolism in these cells toward an increased OXPHOS-based metabolism in differentiated 
cells. The general preference of stem cells for glycolysis may be due to the hypoxic 
environment in the niche in which they normally exist [93][98][99].  
With low oxygen availability, cells must rely on anaerobic glycolysis, which can be 
triggered by the hypoxia-inducible factor 1-alpha (Hif1-α). In fact, hypoxia sustains the self-
renewal state of cultured ESCs and prevents their spontaneous differentiation [100]. This 
metabolic state usually results in increased lactate production [101]. Mouse HSCs exhibit a 
significantly higher utilization of glycolysis and lower reliance on OXPHOS. These cells also 
present a lower oxygen consumption and a strong expression Hif1-α, when compared to 
19 
 
other cells types in the bone marrow [102]. The preferential use of anaerobic glycolysis by 
HSCs is mediated by a pyruvate dehydrogenase kinase (PdK)-dependent mechanism, which 
in normal conditions suppresses the activity of pyruvate dehydrogenase in the mitochondria, 
and consequently inhibits OXPHOS. Importantly, PdK-mutant HSCs display lower lactate 
dehydrogenase activity and reduced self-renewal potential, while maintaining normal 
differentiation capacity, indicating that inhibition of OXPHOS is required for stem cell self-
renewal [103].  
Conversely, differentiated somatic cell lines display increased oxygen consumption 
rates and intracellular ATP content while secreting less lactate, suggesting a preference for 
OXPHOS [96]. Furthermore, differentiation of ESCs and iPSCs is associated with increased 
intracellular ATP levels and lower lactate production, while nuclear reprograming to iPSCs is 
coupled with a shift to glycolysis, and stimulation of glycolysis improves reprogramming 
efficiency, while inhibition of glycolysis decreases it [104].  
Stem cells not only have different metabolic requirements when compared to their 
differentiated progeny, but also exhibit strong shifts in behavior when changes in distinct 
metabolic pathways are induced. Stimulation of mitochondrial biogenesis with 
S-nitrosoacetylpenicillamine (SNAP) in ESCs reduces the expression of pluripotency markers 
and triggers differentiation [97][105][106]. Similarly, overexpression of PGC-1α (peroxisome 
proliferator-activated receptor (PPAR) gamma coactivator-1α) — an important endogenous 
promoter of mitochondrial biogenesis — in mouse iPSCs triggers their differentiation into 
adipocytes [107].  
Conversely, inhibiting mitochondrial function promotes pluripotency and prevents 
differentiation. Mitochondrial uncoupling by CCCP (carbonyl cyanide m-
chlorophenylhydrazone) in ESCs increases the expression of the stemness factors NANOG, 
SOX2, and OCT4 and represses differentiation [108]. Schell and colleagues report that 
inhibition of MPCs (mitochondrial pyruvate carriers) in mouse intestinal stem cells and 
in vitro intestinal cell bodies, stimulates proliferation and population growth. These effects 
are coupled with decreased oxygen consumption and reduced citrate levels, confirming 
lower OXPHOS activity. The authors also show that endogenous MPC expression increases 
following differentiation of ISCs [109]. 
ESCs and iPSCs are more sensitive to inhibition of glycolysis than inhibition of 
OXPHOS for maintenance of normal ATP levels, while the opposite effect is observed in 
differentiated cells [101]. Despite these results, stem cells still rely on OXPHOS at a certain 
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level. Upon OXPHOS inhibition, ESCs and iPSCs still show reduced ATP levels, suggesting that 
OXPHOS also contributes to energy production in these cells [101][110].  
The reports here described reveal that stem cells rely largely on anaerobic glycolysis 
while differentiated cells rely mainly on OXPHOS, and inhibition of OXPHOS is required to 
maintain a stem cell state. Despite that behavior, most cells are metabolically plastic and 
they shift between metabolic states when needed [98]. In the following section, similar 
behaviors are described specifically in the intestinal stem cell niche of Drosophila 
melanogaster. 
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3.3- Metabolism in the Drosophila intestinal progenitor cells 
In similarity with the stem cell types described in the previous section, metabolism 
also plays an important role in the maintenance of intestinal progenitor cells of Drosophila, 
with consequences at a tissue level and animal lifespan. These cells are dependent on 
metabolism in similar ways as the different types of mammalian stem cells and also present 
fewer mitochondria than differentiated cells in the same tissue [111].  
Schell and colleagues, in the study cited in the previous section using mice intestinal 
stem cells [109], also explore the role of mitochondrial pyruvate carriers (MPCs) in ISCs of 
Drosophila. The authors show that ISCs express lower levels of MPCs compared to the other 
differentiated cell types in the intestine, and that inhibition of MPCs causes ISCs to over-
proliferate, while overexpression of MPC suppresses their ability to proliferate. These results 
reinforce the correlation between decreased OXPHOS and increased proliferation, while 
demonstrating a parallel between mammalian and Drosophila intestinal stem cells, in terms 
of metabolic-dependent behavior.  
M. Rera and colleagues, exploring the role of the conserved mitochondrial biogenesis 
regulator dPGC-1 in progenitor cells of Drosophila, show that dPGC-1 overexpression raises 
mitochondrial content and increases the activity of the Krebs cycle enzyme citrate synthase 
and expression of ETC complexes I, III, IV and V. This is accompanied by delayed aging 
phenotypes in the intestine, such as restriction of progenitor cell over-proliferation and 
maintenance of intestinal barrier integrity, resulting in longer lifespan of the fly [112]. This 
work reinforces the correlation between increased aerobic respiration and lower stem cell 
activity, and reveals the importance of proper intestinal progenitor cell function to maintain 
tissue homeostasis, positively impacting the lifespan of the organism. 
Singh et al. show that ISCs rely heavily on lipolysis–beta oxidation, while no evidence 
of activity of these pathways was found in differentiated cells in the intestine. Furthermore, 
attenuation of the lipolysis pathway leads to ISC death by necrosis [113].  Beta oxidation has 
previously been shown to be important for adult neural stem cell maintenance in mice 
[114][115]. 
The aforementioned reports indicate that intestinal progenitor cells in Drosophila, in 
similarity with the different mammalian stem cell types presented in the previous section, 
rely less on OXPHOS than their differentiated counterparts. Despite that, they still depend 
upon mitochondria for maintenance. Accordingly, ablation of the mitochondrial autophagy 
(mitophagy) genes pink and parkin resulting in altered mitochondrial ultrastructure, induces 
a senescence-like state in ISCs, blocking the over-proliferative condition normally observed 
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during aging [111]. Interestingly, while blocking pyruvate uptake by MPC inhibition induces 
ISC over-proliferation, blocking beta oxidation results in necrotic ISC death, indicating that 
these cells might rely on lipolysis-beta oxidation as a energy source to some level, although 
probably not predominantly, since these cells present fewer mitochondria, and the products 
of beta oxidation (acetyl-CoA, NADH and FADH2) require mitochondria to be oxidized in the 
Krebs cycle and the ETC. While these sections showed the general role of glycolysis, beta 
oxidation and OXPHOS in stem cells, the following section focuses on the particular role of 
different complexes of the ETC and its subunits. 
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3.4- Implications of the electron transport chain in cell maintenance 
and organismal longevity 
As described in the previous sections, stem cells are sensitive to ablations of different 
OXPHOS components which commonly correlate with increased proliferation. Inhibition of 
ETC complexes or particular subunits commonly results in similar effects.  
Reprogramming of somatic cells into iPSCs is accompanied by a downregulation of 
several subunits of ETC complexes I and II [104]. In ESCs, inhibition of complex III with 
antimycin A, results in increased expression of stemness genes such as NANOG and OCT4, 
and reduced expression of genes that promote differentiation [110]. In ESCs and iPSCs, 
inhibition of complex V with oligomycin, decreases ATP levels only by less than 5%, 
suggesting that these cells rely only marginally on OXPHOS, or that upon OXPHOS inhibition 
they are able to shift their metabolism to keep up with energetic demands [101]. In mice, 
keratinocyte-specific knockout of mitochondrial transcriptional factor A (TFAM), a key 
activator of transcription in mitochondria, causes a reduction in the activity of complexes I, 
III, IV, and V, but not complex II or citrate synthase, which are not encoded by mitochondrial 
DNA [116]. Accordingly, TFAM-deficient cells exhibit significantly lower oxygen consumption, 
and lower levels of ROS [117]. At a functional level, these cells display impaired 
differentiation, increased proliferation, and no evidence of apoptosis, reinforcing the 
connection between decreased OXPHOS activity and increased proliferation / impaired 
differentiation. Due to the broad number of genes affected by this knockout, it is not clear 
whether the phenotypes arise from inhibition of a particular respiratory complex, or from a 
general downregulation of the aerobic respiration machinery.  
In intestinal progenitor cells of Drosophila, expression of NDI1 — the yeast equivalent 
of ETC complex I (NADH dehydrogenase) — results in increased non-endogenous NADH 
oxidation and inhibits ISC over-proliferation in older flies, while lessening the number of cells 
expressing both markers of differentiated and progenitor cells, which are normal aging 
phenotypes, causing an extension in the lifespan of the fly [56]. These phenotypes are 
coupled with a reduction in the levels of activated (phosphorylated) AMPK (5’ adenosine 
monophosphate-activated protein kinase, that senses high AMP/ATP ratios that occur in low 
energy conditions), independent of insulin signaling.  This work shows that ETC activity, at 
least NADH dehydrogenase, also has an impact in ISCs, and reinforces the correlation 
between increased OXPHOS activity and decreased proliferation.   
Conversely, there are instances where inhibition of ETC components is detrimental to 
stem cell activity. In Drosophila, Mandal et al. demonstrate that low ATP resulting from a 
mutation in complex IV subunit Va (CoVa) causes cell cycle arrest in the late G1 phase in cells 
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of the developing eye disc [118][119]. The authors show that the lower ATP are sufficient to 
sustain survival and differentiation but not to progress through the cell cycle. The cell cycle-
arrest phenotype is caused AMPK phosphorylation due to a higher AMP/ATP ratio, that leads 
to activation of the tumor-suppressor p53 and subsequent degradation of  the G1-S 
transition protein Cyclin E, ultimately causing arrest in G1. Furthermore, the authors show 
that mutations in the PDSW subunit of Complex I and mitochondrial ribosomal proteins 
mRpL4 and mRpL17 also cause cell cycle arrest in the same cells. These data oppose the 
reports previously described, by coupling downregulation of OXPHOS to inhibition of 
proliferation. This raises the question why inhibition of OXPHOS components in the cells of 
the Drosophila developing eye causes cell cycle arrest, while in other stem cells types it 
induces proliferation. It appears to be a cell type-dependent effect since inhibition of 
different components (CoVa, PDSW, mRpL4 and mRpL17) result in a similar phenotype. Since 
the authors describe an ATP-dependent mechanism, it does not appear to be any specific 
mechanism related to the mutations, but rather a special requirement in these cells for the 
wild type gene in ATP production. Perhaps cells in the developing eye of Drosophila are 
unable to counteract the low ATP levels by increasing anaerobic respiration, or do not 
receive enough nutrients to maintain their ATP levels from anaerobic respiration (since this 
process is less efficient) or lipolysis – beta oxidation. A different report shows that oxygen 
deprivation or cyanide treatment (which inhibits cytochrome c oxidase of complex IV in the 
ETC) coupled with a slight reduction in ATP levels cause cell cycle arrest in Drosophila 
embryos [120]. However, the phenotype was not rescued by addition of ATP into the 
embryo, which suggests a different mechanism than the one in the eye disc. 
Copeland and colleagues [121] unraveled the importance of individual subunits of the 
ETC for the lifespan of Drosophila. In a knockdown screen, the authors show that while 
ubiquitous knockdown of specific subunits of the ETC  via RNAi (RNA-interference) results in 
lethality or premature death, knocking down different subunits of the same complexes 
increases longevity in the fruit fly.  The ATP levels and fertility rates of these long-lived flies 
remain unchanged in some of the cases, indicating that the lifespan extension is not caused 
by a general slow-down of biological processes, and suggesting that their cells are able to 
counteract the specific subunit knockdown by shifting metabolism from OXPHOS. It remains 
to be determined what are the specific mechanisms underlying the observed lifespan 
extension. 
In summary, different cell types have different metabolic requirements, although in  
general stem cells rely little on OXPHOS. In parallel, inhibition of OXPHOS generally leads to 
increased stem cell proliferation. ISCs seem to follow this aspect, since inhibition of MPC 
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resulting in downregulated OXPHOS activity leads to increased proliferation; while increased 
mitochondrial or NADH dehydrogenase activity lead to decreased proliferation in older flies. 
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4- Aims and outline of the thesis:  
The reports presented in this chapter show that in general, a depletion of aerobic 
respiration, rather than deleterious, is essential for stem cell division. This has a few 
exceptions that appear to be specific of the cell type.   
Despite the efforts in understanding the role of the ETC in stem cell maintenance, 
several questions related to how different complexes and subunits regulate distinct stem cell 
types still remain. Are different subunits/complexes required in a specific cell type in the 
same manner? Do different cell types have distinct requirements for a specific 
subunit/complex? Through which mechanisms? 
In addition, due to a previous lack of tools with cell-type specificity for ISCs or EBs, 
some studies did not differentiate between these 2 cell types and as such they were treated 
equally [56][112].  Consequently, there is currently a gap in knowledge regarding how 
metabolism regulates these two cell types differently.  
This work aimed at filling the gap in understanding the role of individual ETC complex 
subunits in intestinal progenitor cell maintenance — both in ISCs and EBs — and how it 
affects tissue homeostasis. Given the role of different subunits in the organism in mediating 
lifespan and the tight relationship between lifespan and intestinal stem cell regulation, we 
hypothesized that different ETC subunits may have distinct roles in regulating intestinal 
progenitor cells in Drosophila, with a consequent impact in tissue homeostasis. 
To test this hypothesis, we performed a candidate screen by knocking down several 
subunits of the ETC in intestinal progenitor cells and assess their requirements for cell 
division, differentiation and consequently, proper tissue homeostasis.  
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Thesis outline: 
Screen for the requirement of different ETC subunits in progenitor cells 
To identify ETC subunits that are required for normal function in intestinal progenitor 
cells, we performed a candidate screen to knock down individual subunits specifically in 
these cells. Their abundance in the tissue was compared to controls as a readout of survival, 
self-renewal and differentiation rates. Succinate dehydrogenase subunit D (SdhD) of 
Complex II was identified as a strong candidate, that upon knockdown caused a significant 
reduction in the number of progenitor cells. 
The requirements for SdhD in progenitor cell maintenance 
In this section, I explore the requirements for SdhD in each type of progenitor cells 
(ISCs and EBs) by knocking down SdhD in these cell types individually and characterize its 
phenotypes in terms of survival and self-renewal potential, assessing differences between 
the two cell types.  
The requirements for SdhD in progenitor cell differentiation  
In this part, I explore how knocking down SdhD in progenitor cells affects the 
differentiation choice towards an enterocyte or enteroendocrine fate, by counting the 
number of differentiated cell types upon SdhD knockdown in progenitor cells, and 
performing lineage-tracing analysis. 
Mechanisms originating from SdhD knockdown 
 Finally, I present possible mechanisms originating from SdhD knockdown, particularly 
its effects in the accumulation of succinate, and its possible consequences as a signaling 
molecule. 
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Materials and methods 
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Fly husbandry and stocks 
Flies were raised in vials containing standard cornmeal/molasses/agar medium (in 
weight/volume: 1% agar, 3% brewer’s yeast, 1.9% sucrose, 3.8% dextrose, and 9.1% 
cornmeal). In experiments using RU486 (mifepristone; described below), an ethanol solution 
of the compound was mixed in warm, liquid media at a concentration of 10 µg/ml (0.023 
mM) and let cool down at room temperature. As control, the same volume of ethanol with 
no solute was mixed in the media. RU486 was purchased from Cayman Chemicals, cat. 
#10006317. 
As the homeostatic balance in the fruit-fly intestine is highly dependent on age, 
sexual activity, mating status, and nutritional and environmental conditions, we used special 
precautions to minimize such variations [122]. All flies used for the experiments were mated 
females that were kept in vials with no more than 20 individuals and turned onto fresh food 
vials every 2-3 days. All crosses using RNAi lines were performed at 18 °C, to prevent any 
‘leakage’ expression during development; the progeny was kept at 18 °C until 2-3 days after 
eclosion and then switched to 25 °C, or 29 °C for flies containing a temperature-sensitive 
construct (Gal80TS, described below), and maintained on a 12-hour light-dark cycle.  
All stocks contained a CyO balancer on the second chromosome (II) and a TM3 (third 
multiple) or TM6 balancer on the third (III), which have several inversions to suppress 
meiotic recombination. Throughout the text, these are omitted for simplicity. 
The GAL4-UAS system 
The GAL4-UAS system allows expression of genes of interest in specific cell types, via 
the Saccharomyces cerevisiae transcriptional activator GAL4 and the Upstream Activating 
Sequences (UAS) transcription promoter element. GAL4 binds to UAS genomic sequences, 
which in turn promotes the expression of a responder gene of choice [123][35]. To achieve 
this, flies carrying a promoter for a gene specific for cell type (ex.: esg for progenitor cells) 
that initiates GAL4 expression (the duo is termed driver) are crossed to flies that carry a UAS 
sequence promoting a responder gene (ex.: UAS-GFP (Green fluorescent protein)).  In this 
example, expression of GAL4 in progenitor cells promoted by esg activates the UAS element 
which induces expression of GPF in these cells. Uses other than GFP reporters include RNA-
interference, fluorescent probes, or overexpression of endogenous  genes, among others.  
A chimeric version of GAL4 containing a progesterone receptor-ligand-binding 
domain allows activation of GAL4 only upon binding of the antiprogestin RU486, which can 
be added to the meal preparation to timely activate GAL4 expression, a system that is 
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named P{Switch} [124]. As an example, to avoid expression during development, the flies are 
kept on normal food and upon reaching adulthood are shifted to RU486-containing food. A 
different method to achieve time-sensitive expression is to co-express the temperature-
sensitive GAL4-inhibitor GAL80 from yeast, also termed Gal80TS. When flies are incubated at 
18 °C, GAL80 inhibits GAL4 activity; however, when the incubation temperature is raised to 
29 °C, GAL80 is degraded and Gal4 becomes active [35][125].  
Drivers of gene expression in progenitor cells  
The Su(H)-LacZ; 5961-Gal4GS,esg-GFPNLS line was used to drive Gal4 expression in 
progenitor cells (ISCs and EBs). The 5961-Gal4GS construct originated from a large screen 
consisting of insertions of enhancer-trap P{Switch} elements throughout the genome [126]. 
With this construct, GAL4 expression was observed in progenitor cells upon RU486 feeding 
[127]. This line contains a LacZ gene originally from Escherichia coli that encodes β-
galactosidase (β-Gal) and is expressed under the control of Su(H) to mark EBs, using anti-β-
Gal antibodies. The esg-GFPNLS reporter expresses a nuclear-localizing GFP in progenitor cells, 
independent of GAL4 activity. The 5961GS line was a gift from B. Ohlstein and esg-GFPNLS a 
gift from L. Cooley; these two constructs were previously recombined by other members of 
the Jones laboratory at University of California, Los Angeles to generate the aforementioned 
line. Throughout the text, this line is simply referred to as 5961-Gal4GS. 
The Su(H)-LacZ; esg-Gal4,UAS-GFP,tub-Gal80TS line (referred to simply as esg-Gal4) 
was also used to drive expression in progenitor cells. Both GFP (via GAL4-UAS) and GAL4 are 
expressed in progenitor cells under the control of esg. When flies are incubated at 18 °C, 
expression of GAL4 is inhibited by the ubiquitously-expressed GAL80 (under the control of 
tubulin), but becomes active when flies are switched to 29 °C, enabling expression of the 
genes downstream of UAS. The original esg-Gal4,UAS-GFP,tub-Gal80TS [128] stock was a gift 
from B. Edgar (Huntsman Cancer Institute, Salt Lake City, USA) and was combined with the 
Su(H)-LacZ line (1st chromosome). 
ISC-specific driver 
The esg-Gal4,Su(H)-Gal80,UAS-2xYFP; tub-Gal80TS driver was used to drive GAL4 
expression specifically in ISCs [129]. This line works similarly to the esg-Gal4 driver (above) 
but contains a Su(H)-Gal80 sequence to express GAL80 in EBs, which blocks GAL4 expression 
in these cells, restricting GAL4 expression to only ISCs. It also expresses 2 copies of YFP 
(yellow fluorescent protein) in ISCs that can be marked using anti-GFP antibodies, as these 
are also specific for YFP. GAL80 is expressed under the control of tubulin to inhibit GAL4 
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expression during development. This driver was a gift from S. Hou (Center for Cancer 
Research, National Cancer Institute, Frederick, USA).  
Enteroblast-specific driver 
The Su(H)‐Gal4,UAS‐GFP; tubGal80TS line drives expression of GAL4 and GFP in EBs 
under the control of Su(H) [45]. The tubGal80TS construct allows temporal-specific control of 
GAL4 expression. This line was a gift from S. Hou (Center for Cancer Research, National 
Cancer Institute, Frederick, USA). 
Other drivers 
The RU486-sensitive, EC-specific, 5966-Gal4GS driver (referred to as 5966GS) 
originated from the same screen as the 5961GS [127] and was provided by H. Jasper (Buck 
Institute for Research on Aging, Novato, USA). The tub-Gal4, Gal80TS was originally 
developed by Lee and colleagues [130] and drives ubiquitous expression of GAL4.  
The lineage-tracing tool esg-Gal4,tub-Gal80TS,UAS-GFP; UAS-flp,act>CD2>Gal4, 
termed esg-FlipOut expresses the recombinase Flippase (Flp) in progenitor cells under the 
control of esg-Gal4 (and Gal80TS) which promotes the excision of the CD2 stop codon, 
allowing expression of Gal4 under the control of the ubiquitously expressed Actin (Act) to 
also mark daughter cells with GFP [58][131]. This line was a gift from B. Edgar (Huntsman 
Cancer Institute, Salt Lake City, USA).  
RNAi lines 
The RNAi lines used in the initial screening were a gift from David Walker (UCLA, Los 
Angeles, USA) and were originally obtained from the Vienna Drosophila Resource Center 
(VDRC) [132]. These lines are listed on Table 1 in section 1 of the Results and discussion 
chapter. The 2 other RNAi lines targeting SdhD were 10219R-1 (SdhDNIG.10219R), obtained 
from NIG-Fly Stock Center [133] and 26776 GD from VDRC. The RNAi line against super oxide 
dismutase 2 (SOD2-RNAi) was acquired from the Bloomington stock center (Indiana 
University, Bloomington, USA; stock #24484).  
Other stocks 
The pKC43 line (obtained from VDRC) was used as control for all the KK type VDRC 
lines, as it contains the equivalent vector that was used to host the RNAi sequences, that 
lands in the same genomic regions [134]. In this line, the vector contains no RNAi sequence, 
offering a genetic background identical to that of the RNAi line. For RNAi lines other than the 
KK collection, the w1118 line was used as control to match their genetic background. 
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The line for overexpression of the pro-apoptotic genes reaper (rpr) and head 
involution defective (hid), UAS-rpr,UAS-hid, was a gift from E. Rulifson. The Apoliner reporter 
was a gift from M. Resnik (UCLA, Los Angeles, USA). The Mito-roGFP  probe was a gift from 
R. Demarco (UCLA, Los Angeles, USA).  
Immuno-fluorescence 
Samples were prepared following standard procedures [135]. Intestine were 
dissected whole in phosphate‐buffered saline (PBS) solution, fixed in 4 % paraformaldehyde 
(PFA) for 40 minutes, washed 3X for 10 minutes in PBST (0.1% Triton X in PBS), blocked in 
0.3% bovine serum albumin (BSA) in PBST for 30 minutes, incubated in primary antibodies 
for 4 hours, washed 3X in PBST, incubated in secondary antibodies for 2 hours, washed 3X in 
PBST and finally incubated for 10 minutes in Vectashield + DAPI (Vector Laboratories, 
Burlingame, USA). The samples were then mounted on slides in the same media.   
Antibodies 
The following primary antibodies were used: mouse anti-Prospero (at a concentration 
of 1:100), mouse anti-Snakeskin (SSK, 1:10) and mouse Anti-Armadillo (1:10), obtained from 
the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and 
maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. Rabbit 
anti-phosphohistone H3 (pHH3) from EMD Millipore, Darmstadt, Germany. Rabbit anti-GFP 
(1:5000) from Molecular Probes, Eugene, USA. Chicken anti-β-Gal (1:100) and chicken anti-
GFP (1:200) from Aves Labs, Tigard, USA. The chicken anti-GFP antibody was observed to 
recognize YFP molecule expressed in the ISC-specific driver esg-Gal4,Su(H)-Gal80,UAS-2xYFP; 
tub-GAL80TS. Cell membranes were stained with anti-Armadillo antibodies (the Drosophila 
homologue of beta-catenin) at a concentration of 1:10. Rabbit anti-cleaved-Caspase 3 was 
obtained from Cell Signaling, Danvers, USA (item #9664). 
The secondary antibodies used were  the following: Alexa Fluor anti-rabbit 488, anti-
chicken 488, anti-mouse 568, anti-mouse 594, anti-mouse 633 and anti-rabbit 647, obtained 
from Molecular Probes and diluted 1:500 in PBST+BSA.  
qRT-PCR 
The enterocyte-specific 5966GS driver was used, since enterocytes constitute most of 
cell mass in the midgut and only whole midguts were used for mRNA extraction. Adult flies 
were raised in standard conditions on food containing RU486 or only ethanol for 2 days and 
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70 intestines on each group were dissected whole and immediately frozen at -80 °C. The 
samples were prepared according to manufacturer instructions and previous reports [45]: a 
premix of Trizol (Life Technologies, #15596026) was prepared using the following amounts 
(per sample): 100 µl of Trizol, 100 ng of tRNA (in water containing diethyl pyrocarbonate 
(DEPC) to inactivate RNase enzymes), 0.2 µl linear polyacrylamide (LPA; Sigma-Aldrich 
56575). A 100 µl of this premix was added to each sample. The suspension was frozen in 
liquid nitrogen and thawed in water at 37 °C, and repeated 5 times. The suspension was 
vortexed for 5 minutes at room temperature and left settling for 30 seconds. The procedure 
was repeated 5 times and then left settling again for 5 minutes. 20 µl of chloroform were 
added, followed by 15 seconds of vigorous shaking. The tubes were then centrifuged at 
10,000 RPM for 15 minutes at 4 °C. 60 microliters of isopropanol were then added to a clean 
tube and the previous aqueous solution was added on top. The tubes were shaken, vortexed 
and left settling for 10 minutes at room temperature. The tubes were then centrifuged for 
15 minutes at 13,000 RPM and the supernatant was removed. Five hundred microliters of 70 
% ethanol in water was added to the remaining pellet and left at -80 °C for 30 minutes. 
Tubes were again centrifuged, the supernatant removed, and the pellet allowed to air-dry 
for 5 minutes, and finally re-dissolved it in DEPC water solution. 
The samples were then treated with DNase by mixing 1 µl of buffer with 1.5 µl DNase 
(Promega, cat#M610A) and 1.5 µg of RNA in DEPC water was added to a final volume of 10 
µl. The mixture was incubated for 30 minutes at 37 °C, after which 1 µl of stop solution was 
added and incubated for 10 minutes at 65 °C. For the reverse transcriptase (RT) reaction, 
7.33 µl of RNA in solution were mixed with 4 µl of RT mix (iScript kit, Bio-Rad, #170- 8841) 
and water was added to a final volume of 20 µl. A no-RT reaction was run in parallel to the 
control. The reaction ran for 5 minutes at 25 °C, followed by 30 minutes at 42 °C and finally 5 
minutes at 85 °C.  
For qPCR reactions, forward and reverse primers were equally combined in the same 
aliquot at a concentration of 4 µM in water. For each well were added 10 µl of SYBR Green 
(Bio-Rad, #1725-264), 2.5 µl of 0.5 µM oligonucleotides solution, 6.5 µl of water and 1 µl of 
cDNA solution.  Dilutions were performed in the ratios of 1:1, 1:5, 1:25 and 1:125. Plates 
were strongly vortexed and then centrifuged to settle down the solution. The samples were 
run in triplicate. Thermocycler settings: 30 minutes at 95 °C, and 40 cycles of 5 min at 95 °C, 
plus 30 min at 62 °C. Equipment: CFX96/C1000 Touch system (Bio-Rad). 
Primers used: SdhD (CG10219) Forward: ACTCCCCTGAAGAGCTACTCC, 
Reverse: ACGGGCGCTACAATCTTGG; PTPMT1 (CG10371) Fwd: CGTTTCCTTCTACCCCACCC, 
Rev: CCCAGTATCACATGCTCATCG; RP49 Fwd: ATCGTGAAGAAGCGCACCAA; 
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Rev: TGTCGATACCCTTGGGCTTG. All primers were manufactured by IdT Technologies, Iowa, 
USA.  
Assessment of oxidative state using the mito-roGFP probe 
The genetically-encoded Mito-roGFP reporter was used to quantify the ratio of 
oxidative/reductive potential within progenitor cells. This construct consists of a modified 
GFP protein containing two cysteines that, upon oxidation, form a disulfide bond between 
the both, shifting the excitation wavelength of GFP [136]. The ratio of oxidized/reduced GFP 
can then be determined by exciting the protein under a confocal microscope using two 
different excitation wavelengths – 405 nm for the oxidized molecule and 476 nm for the 
reduced - and acquiring the corresponding green signal for each of the excitation 
wavelengths. The ratio between intensity of emission in the green spectrum for each of the 
excitation wavelengths is a read-out of the oxidative environment within the cell. In an 
oxidizing environment, the ratio of the oxidation/reduction is higher than that in normal 
conditions. This specific probe localizes to the mitochondria.  
The intestines were quickly dissected in PBS on ice. Samples for reduced or oxidized 
controls were incubated in the reducing agent DTT (1,4-Dithiothreitol; 10 mM; Sigma D0632) 
or the oxidizer Diamide (1 mM; Sigma D3648), respectively, for 30 minutes. Both samples 
were dissolved in a solution of PLP cofactor (Pyridoxal 5′-phosphate; Sigma P9255)and then 
moved to a solution containing NEM (N-Ethylmaleimide;  Sigma E1271) and 4% PFA fixatives 
in PLP for 30 minutes and subject to a standard immunostaining protocol, while protecting 
from light. Positive controls were confirmed to be oxidized or reduced by exhibiting a strong 
signal in the corresponding channels. Anti-armadillo antibodies were used to stain cell 
membranes. 
Imaging and cell counting 
This work focused on the P3-P4 region of the Drosophila midgut (previously described 
in a characterization of the intestinal morphology and function [122]), as it is the region 
where most of the research in progenitor cells in the intestine of Drosophila cited in this 
thesis is focused on. Intestines were observed under a Zeiss LSM 710 Laser Scanning confocal 
microscope, using 40X or 63X objectives and scanned as z-stacks of approximately 1 µm 
thickness each, capturing all ISCs, EBs, EEs and ECs in the field of view (FOV). Z-stacks were 
converted to maximum intensity projections using an automated plug-in running on the Fiji 
software (ImageJ) [137]. Maximum intensity projections were then imported into Cell 
Profiler [138] where the cells were automatically counted, according to their fluorophore 
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color and size. The number of cells of interest per FOV was normalized to the total number 
of cells in the same FOV (marked by the nuclear stain DAPI). Statistical analyses were 
performed using the GraphPad Prism version 5.03, GraphPad Software. The significance in 
cell counting experiments was determined using a two-tailed, unpaired Student’s t-test and 
expressed as p values. 
Apoptag kit for detection of apoptosis (TUNEL assay) 
The test used to detect apoptosis is based on the TUNEL assay (Terminal 
deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling) which detects fragmented DNA 
ends characteristic of apoptotic cells, by addition of modified nucleotides that can be 
detected with antibodies [139][140]. The DNA strand breaks are detected by enzymatically 
labeling the free 3'-OH termini — that are found in apoptotic cells — with modified 
digoxigenin(DIG)-nucleotides, by catalytic action of the terminal deoxynucleotidyl 
transferase (TdT) enzyme. Anti-DIG antibodies conjugated to a peroxidase reporter are then 
used to label DIG-nucleotides. 
The Apoptag kit (red) was purchased from Chemicon International (Temecula, USA 
#S7165), the anti-DIG-POD from Roche (# 11 207 733 910) and Tyramide Signal Amplification 
(TSA) fluorescence kits from PerkinElmer.  
The protocol was performed according to manufacturer instructions: intestines were 
dissected in PBS on ice, fixed in 2% paraformaldehyde in PLP for 30 minutes, rinsed in PBST, 
incubated 2x 10 minutes in PBST + Na-deoxycholate (0.3%), rinsed twice in PBST, rinsed 
twice in equilibrium buffer and incubated for 2 minutes at room temperature in the same 
buffer. Samples were then incubated in reaction buffer with DNA-polymerase TdT enzyme 
(in a 7:3 ratio for 1 hour at 37 °C, rinsed with stop/wash solution and incubated for 10 
minutes in the same solution, rinsed and washed in PBST and blocked in TNB blocking buffer 
(0.1M Tris-HCl, pH 7.5, 0.15M NaCl, 0.5 % blocking reagent) for 30 minutes, incubated in 
sheep anti-DIG-POD antibody in TNB overnight at 4 °C, washed with PBT, incubated in a 
solution of TSA-cyanine 3 diluted 1:50 in amplification diluent for 30 minutes at room 
temperature and finally washed in PBST and mounted in Vectashield.    
Quantification of succinate by GC-MS 
Gas chromatography – mass spectrometry (GC-MS) is a standard analytical method 
for precise detection, identification, and quantification of different molecules. A 
chromatographic column offers a high separation rate between different analytes in the 
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sample (mobile phase) dependent on their interaction with the column (stationary phase) 
and on the temperature at which the column is. Following separation, analytes then enter 
the mass spectrometer where they are bombarded by electrons and split into several ionic 
components, to finally reach a detector that determines their mass-to-charge ratio (charge is 
usually +1 or -1) and abundance. Analysis of the mass of the split components allows for 
identification of the original compound by comparison of the obtained spectra with that of 
an empirical library of known compounds, or alternatively, predicted theoretical spectra. GC-
MS offers a strong advantage that in a ~30-minute run is able to detect and quantify several 
compounds, in contrast to colorimetric assays that normally only allow for the quantification 
of one single analyte at a time [141].  
Gas chromatography requires analyzed molecules to be volatile, so they can enter 
the column in the gaseous phase. Succinic acid (succinate at biological pH) is not readily 
volatile and therefore needs to be derivatized. The derivatization of succinic acid consists in 
replacing the hydrogens in its hydroxyl groups (-OH) with a trimethylsilyl group (-3(CH3)Si) 
(Figure 3). This is achieved by combining N-Methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA, Sigma #M7891) with the sample in a reaction termed “silylation” (named after its 
silicone-containing group), resulting in succinic acid bis(trimethylsilyl) ester (abbreviated as 
succinic acid 2TMS). Derivatization eliminates the strong interactions between the hydroxyl 
groups of neighboring molecules, resulting in increased volatility and thermal stability, which 
provides a better separation between different molecules and a more precise quantification 
[142].  
 
 
Figure 3: Derivatization of succinic acid 
Derivatization of succinic acid (A) by reacting with MSTFA (N-Methyl-N-(trimethylsilyl) trifluoroacetamide), in 
which the hydrogen atoms in the hydroxyl group (-OH) are replaced by a trimethylsilyl group (−Si(CH3)3), 
obtaining its silylated derivative, succinic acid bis(trimethylsilyl) ester (abbreviated as succinic acid 2TMS) (B). 
Images obtained from the NIST online library [143]. 
 
Extraction of fruit-fly samples for succinate quantification  
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Control (pKC43) and SdhD-RNAi (101739 KK) flies were crossed to the ubiquitous 
tub-Gal4,Gal80TS driver, that expresses Gal4 under the control of tubulin and Gal80TS. 
Parental flies were crossed at 18 °C and progeny was switched to 29 °C 2-3 days after 
eclosion and incubated for 13 days before extraction.  
The extraction process was based on previous reports [144][145]. 15 flies on each 
group, with 3 biological replicates, were anesthetized using CO2, placed in a 1.5 mL 
Eppendorf tube, immediately washed twice in cold 1X PBS, and soaked in 500 µL 90% 
methanol in water at -20 °C. Flies were then homogenized manually using a small plastic 
pestle, snap-frozen in liquid nitrogen and thawed twice, and incubated for 1 h at -20 °C. 
Tubes were then centrifuged at 10,000 rpm for 10 min, the supernatant was extracted to a 
new tube and a second extraction was performed using 60 % methanol at -20 °C. The 
supernatants were combined and lyophilized at -50 °C under vacuum. To the dry extracts 
was added 30 µl of acetonitrile (ACN) solvent and 90 µL MSTFA and incubated at room 
temperature for 2 hours. ACN was chosen for its ability to dissolve succinic acid. 
GC-MS equipment and parameters 
The experiments were performed on a Thermo Scientific ITQ 900 Trace GC Ultra 
device equipped with a DB5 column, using analytical-grade Helium as a carrier gas. The 
software Thermo Xcalibur was used for acquisition and the Thermo Xcalibur Qual Browser 
2.2 with a set of NIST MS libraries (NIST v7, Mass Spectrometry Data Center, National 
Institute of Standards and Technology, Gaithersburg, USA ) was used for compound 
identification. 
The following sampling parameters were used: 3 plunger strokes, pre-injection of 5.0 
µL and needle wash with 40 µL ACN. 1 µL of sample was delivered to the injector at 250 °C. 
Oven: Initial temperature of 60 °C for 1 min and increase 10 °C/min up to 250 °C, resulting in 
a run time of about 20 min; Helium flow of 1 mL/min; transfer line at 290 °C; solvent delay of 
8.50 min; ion source at 230 °C; MS oven at 150 °C; mass range of 50 to 600 m/z.  
Succinic acid (purchased from Sigma, #S9512) was derivatized to succinic acid 2TMS 
and used as a standard to provide a location reference in the chromatogram and to confirm 
its mass spectra. Control and SdhD-RNAi samples were analyzed in random order, with 3 
ACN cleaning cycles and 1 ACN+MSTFA cycle as cleaning/negative control in between. 
Succinic acid 2TMS in samples was identified in the same region in the chromatogram 
as the standard sample (at a retention time of 14.04 minutes). Peak detection and 
calculation of area were performed automatically by the Thermo Xcalibur Qual Browser v. 
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2.2 software, using absolute intensity values. Ares of the peaks (in arbitrary units) 
corresponding to the amounts of succinate in control and RNAi groups were then exported 
to the Graphpad Prism software (v5.03) for statistical analysis.
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Results and discussion 
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I - Screen for electron transport chain subunits with an 
impact in progenitor cell activity 
To assess the requirement for individual subunits of the ETC in intestinal progenitor 
cells (ISCs and EBs), we performed a candidate screen that consisted in knocking down 
different ETC subunits specifically in progenitor cells by means of RNAi. The abundance of 
progenitor cells in the tissue after RNAi expression was used as a read-out of the screen to 
determine changes in survival, proliferation or differentiation rates. 
Specific genes were chosen for their importance in terms of structural roles (such as 
complex I assembly factor, CIA30), enzymatic activity (SdhA) or direct electron transport 
function (Cyt-C1L) according to published reports cited in Flybase [146]. These lines also 
target genes that, upon ubiquitous constitutive knockdown, resulted in lethality or changes 
in the lifespan of flies in the study by Copeland and colleagues mentioned in the Introduction 
chapter [121] (section 3.4). These RNAi lines and corresponding genes are listed in Table 1.  
Activation of RNAi expression specifically in intestinal progenitor cells was induced by 
the driver Su(H)-LacZ; 5961-Gal4GS,esg-GFPNLS (5961GS), which is activated by the drug RU486 
(referred to as RU from hereon now) that is dissolved in ethanol (EtOH) and added to the fly 
meal. As schematized in Figure 4, female flies containing the UAS-RNAi sequence for each of 
the genes of interest were crossed with males carrying the 5961GS line containing an 
esg-GFPNLS reporter that expresses GFP localizing to the nuclei of progenitor cells, to identify 
these cells. Fly crosses were set up on vials containing normal food (no RU or ethanol), and 
were kept at 18 °C to minimize any possible ‘leakage’ of RNAi expression during 
development. Upon reaching adulthood, 2-3 days after eclosion, flies were separated into 
two groups: one in vials containing food where a solution of RU in ethanol was added (to 
activate RNAi expression), and the second where only ethanol was added to the food, as 
isogenic controls with no RNAi expression. Flies were left on each type of food for 8 days at 
25 °C, at which point the intestines were dissected, prepared for immunofluorescence and 
scanned under a fluorescence microscope, obtaining several sections to cover all ISCs, EBs, 
ECs and EEs, and processed as z-stack projections.  
 
Table 1: List of RNAi lines selected for the candidate screen 
Complex Symbol Name of target  Annotation VDRC stock ID 
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Maximum-intensity projections of immunofluorescence images were loaded into the 
Cell Profiler software [138] to automatically identify and count the population of progenitor 
cells (GFP-positive) and the number of total cells in the field of view (marked by the nuclear 
Complex 
I 
CIA30 
Complex I intermediate-associated 
protein, 30 kDa (assembly factor) 
CG7598 14859 GD 
ND-B12 
NADH dehydrogenase (ubiquinone) B12 
subunit 
CG10320 104890 KK 
ND-13A 
NADH dehydrogenase (ubiquinone) 13 
kDa A subunit 
CG8680 102017 KK 
ND-PDSW 
NADH dehydrogenase (ubiquinone) 
PDSW subunit 
CG8844 106095 KK 
ND-ACP 
NADH dehydrogenase (ubiquinone) acyl 
carrier protein 
CG9160 107907 KK 
ND-18 
NADH dehydrogenase (ubiquinone) 18 
kDa subunit 
CG12203 101489 KK 
ND-B14 
NADH dehydrogenase (ubiquinone) B14 
subunit 
CG7712 100616 KK 
Complex 
II 
SdhAL 
Succinate dehydrogenase, subunit A 
(flavoprotein)-like 
CG5718 
 
100071 KK 
42443 GD 
SdhC Succinate dehydrogenase, subunit C CG6666 6031 GD 
SdhD Succinate dehydrogenase, subunit D CG10219 101739 KK 
Complex 
III 
UQCR-C2 
Ubiquinol-cytochrome c reductase core 
protein 2 
CG4169 100818 KK 
Cyt-C1L Cytochrome c1-like  CG14508 106229 KK 
UQCR-Q 
Ubiquinol-cytochrome c reductase 
ubiquinone-binding protein 
CG7580 101371 KK 
Complex 
IV 
COX7C Cytochrome c oxidase subunit 7C CG2249 104970 KK 
COX4L Cytochrome c oxidase subunit 4-like CG10396 106700 KK 
COX6B Cytochrome c oxidase subunit 6B CG14235 20702 GD 
COX4 Cytochrome c oxidase subunit 4 CG10664 3923 GD 
 
18 °C 
8 days  
♀ UAS-RNAi line x ♂ 5961GS progenitor-cell 
driver 
Ethanol Control 
(RNAi OFF) 
RU486  
(RNAi ON) 
 
eclosion Figure 4: Candidate screen workflow diagram 
To knock down individual subunits of the ETC in progenitor cells (ISCs and EBs), females containing each RNAi 
construct were crossed with males carrying the progenitor cell-specific driver Su(H)-LacZ; 5961
GS
,esg-GFP and 
incubated at 18 °C, to minimize any possible RNAi leaking during development. Upon reaching adulthood 
(2-3 days after eclosion), progeny were separated into vials containing food mixed with an ethanol solution of 
the drug RU486 to induce RNAi expression, and vials containing only food with the vehicle ethanol, as control. 
Both groups were then incubated at 25 °C for 8 days, after which the intestines were dissected for 
immunofluorescence, scanned under the microscope and the numbers of cells were counted.
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stain DAPI). The abundance of progenitor cells in the region of interest (corresponding to 1 
field of view) was obtained as the number of progenitor cells divided by the total number of 
cells (DAPI-positive). Data for each intestine were plotted as a circle (control) or a square 
(RNAi) and grouped for each RNAi line (Figure 5). 
The RNAi line producing the most significant phenotype was subunit D of complex II 
(SdhD), that caused a substantial decrease in the abundance of progenitor cells. Knockdown 
of subunit C of complex II (SdhC) also resulted in a significant decrease in the population of 
progenitor cells, albeit more modest, which suggests a complex II-specific role that will be 
discussed later in section 4.3. Knockdown of SdhA with 2 different RNAi lines, however, 
resulted in a modest, non-significant increase in the number of these cells. In the study by 
Copeland and colleagues [121], ubiquitous knockdown of SdhA (42443 GD line) during 
development and adulthood increased lifespan up to about 27%, while knockdown of SdhC 
was semi-lethal (resulted in low numbers of adult progeny), and knockdown of SdhD was 
lethal (no adult progeny).  These data show an interesting correlation between the resulting 
abundance of progenitor cells  in our screen and lethality/lifespan in the aforementioned 
study.   
In complex I, RNAi against CIA30 resulted in an increase in the number of progenitor 
cells. In the Copeland study, knockdown of ND-B12, ND-13A, ND-PDSW and ND-ACP resulted 
in lethality and ND-18 was semi-lethal, correlating again with a (small) decrease in the 
abundance of progenitor cells in our screen. RNAi against PDSW of complex I, previously 
mentioned in section 3.4 as its mutant allele causing cell cycle arrest in the developing eye of 
Drosophila, showed only a small, non-significant reduction in the number of progenitor cells 
when compared to controls, suggesting that PDSW is not required in progenitor cells, or 
alternatively, that RNAi knockdown did not lower its levels as much as the mutation, eliciting 
only a mild effect.  
 In complex III, expression of UQCR-C2 RNAi resulted in a mild, non-significant reduction 
in the abundance of progenitor cells, and in the Copeland study resulted in reduced lifespan 
to about 58% of controls. In the same study, expression of RNAi against COX7C of complex IV 
resulted in a 57.1% increase in lifespan, while in the present screen it did not result in any 
significant changes.  
There seems to be a general correlation between reduction in the abundance of 
intestinal progenitor cells and lethality upon expression of different subunits, suggesting that 
intestinal progenitor cells are sensitive to knockdown of ETC subunits in a similar manner to 
other cells during development.  
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Overall, the average number of normalized progenitor cells in EtOH controls shows a 
strong variance between different RNAi lines. We attribute this to differences in genetic 
backgrounds despite the GD and KK collections being supposedly isogenic; or, an example of 
the sensitivity of intestinal homeostasis that could shift upon very small environmental 
changes. Furthermore, the datapoints for each group show a strong variance between them, 
which is more visible in complex I. The focus of this project was on SdhD of complex II as it 
showed a strong significance and more solid data. 
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Figure 5: Results of candidate screen for regulators of progenitor cell activity  
Number of progenitor cells (GFP-)
 
adjusted to the total number of cells (DAPI
+
) obtained in the same field of view, 
plotted for each ETC subunit as control (EtOH, circles) vs RNAi (RU, squares). Horizontal lines in plots represent means 
of the obtained values, with standard error of the mean (SEM). n refers to the number of individuals in each group. 
RNAi of SdhD of Complex II resulted in the most significant phenotype, causing a reduction in the number of 
progenitor cells, which was also observed at a smaller scale with SdhC knockdown. Unpaired two-tailed Student’s t-
test. n.s.: non-significant difference (p>0.05); *: p≤0.05; **: p<0.01; ***: p<0.001. 
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1.1- Knockdown of succinate dehydrogenase subunit D in progenitor 
cells causes a decrease in its population 
The immunostaining images below (Figure 6) show the effects of SdhD-RNAi for 8 days 
in progenitor cells of the intestine (marked with GFP, in green; isolated in the panels in the 
middle, in grey), representative of the quantifications in Figure 5. These data show a reduced 
abundance of progenitor cells in the SdhD-RNAi group (lower panels) when compared to 
controls (upper panels). The DAPI channels showing the nuclei of all cell types are isolated in 
the panels on the right. 
 
Figure 6: Effects of SdhD knockdown in progenitor cells using the 5961
GS
 driver 
Immunofluorescence images acquired perpendicularly to the intestinal axis, processed to maximum z stack 
projections, depicting representative examples of control (EtOH, upper panels) vs SdhD knockdown (RU, lower 
panels) after 8 days of RNAi expression in progenitor cells, using the 5961
GS
 driver. Progenitor cells are shown in 
the left panels in green, marked by an esg-GFP
NLS
 reporter and isolated in greyscale the panels in the middle. 
Cell nuclei were stained with DAPI (isolated in panels on the right). SdhD knockdown produced a decrease in 
the number of progenitor cells, as shown here and quantified in the graph in Figure 5. Scale bars = 50 µm. n=19 
in the EtOH group and n=17 in the RU (SdhD-RNAi) group. 
To validate the SdhD-knockdown phenotype observed in the screen, we repeated the 
experiments using the progenitor cell-specific Su(H)-LacZ; esg-Gal4,UAS-GFP,tub-Gal80TS 
driver (referred to simply as esg-Gal4; described in the Materials and Methods section) that 
in similarity with the 5961GS driver, activates expression of GAL4 in both ISCs and EBs. This 
line also contains a Su(H)-LacZ reporter that induces LacZ expression in EBs, allowing for 
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individual identification of both cell types. Flies were kept at 18 °C during development to 
repress RNAi expression, and were switched to 29 °C 2-3 days after eclosion, to induce SdhD-
RNAi. 
Knockdown of SdhD in progenitor cells using the esg-Gal4 driver causes a sharp 
decrease in their population at day 6 (Figure 7 A, quantified in B), as revealed by GFP 
staining (in green on the left panels; isolated in greyscale in the middle panels).  These 
results are in accordance with the data shown for the 5961GS driver in the screen; in the 
present case, however, the phenotype is stronger, which is attributed to a stronger 
expression of the esg-Gal4 driver as previously observed [45][147]. With the Su(H)-LacZ 
reporter and antibodies against β-Gal (the product of LacZ; isolated in greyscale in the panels 
on the right), ISCs and EBs were identified separately and their numbers were assessed.  The 
abundance of both ISCs and EBs was significantly reduced, as shown in the graphics. These 
results were partially validated using other two different RNAi lines against SdhD (26776 GD 
and 10219R-1; Supplemental Figure 1). Although the number of ISCs is only slightly, non-
significantly reduced with the two different SdhD-RNAi lines, the number of EBs is 
significantly reduced as in the case of the 101739KK RNAi line described here. The 
occurrence of progenitor cell pairs appears to be reduced in the 3 cases, which is attributed 
to loss of EBs. Differences in phenotype strength between the different RNAi lines against 
SdhD are attributed to variations in RNAi effectiveness of each line.  
 
Figure 7: Effects of SdhD knockdown in progenitor cells using the esg-gal4 driver 
A. Knockdown of SdhD in progenitor cells (marked with GFP) using the progenitor cell-specific esg-Gal4 driver, 
crossed to the 101739KK SdhD-RNAi line (lower panel), or pKC43 empty-vector control (upper panel). A visible 
reduction in the number of progenitor cells (isolated in the panels in the middle) is observed after 6 days of 
RNAi expression, when compared to controls. LacZ staining reveals that the number of EBs is strongly reduced 
(panels on the right) in SdhD-RNAi individuals (lower right panels). B. The number of ISCs per field of view was 
quantified by subtracting the number of LacZ
+
 cells (EBs) from the number of GFP
+ 
cells (ISCs+EBs), and was 
 52 
 
divided by the total number of cells in the same field of view and plotted in the graphic (in green), showing a 
significant reduction in their abundance. The numbers of EBs are also significantly reduced, as seen in the 
orange plots. n=24 in control group and n=30 in SdhD-RNAi. Lines represent mean with SEM. Unpaired two-
tailed Student’s t-test. Scale bars = 50 µm.
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2.1.2 Depletion of progenitor cells using the esg-Gal4 driver occurs in a gradual 
manner 
To characterize the effects of SdhD depletion in progenitor cells over time, SdhD-
RNAi was expressed in these cells using the esg-Gal4 driver and intestines were analyzed 
after 15 and 30 days. Inhibition of SdhD for 15 days further reduced the abundance of 
progenitor cells (Figure 8 A’, quantified in A’’) when compared to day 6 (Figure 7 A  in the 
previous section, lower panels), and eventually reached zero in most samples at day 30 (B’, 
quantified in B’’). In contrast, control flies display increasing numbers of GFP-positive cells at 
day 15 (A) and 30 (B) (quantified in A’’ and B’’), as a normal aging phenotype (as described in 
part 2 of the Introduction chapter). SdhD-RNAi progenitor cells at day 15 (A’) appear to be 
shrunk, which will be discussed in section 2.3. It has previously been shown that intestines 
maintain their population of differentiated cells (EEs and ECs) for at least 20 days following 
complete ablation of progenitor cells, suggesting that maintenance of differentiated cells is 
possible without progenitor cells, at least in unchallenged conditions  [148]. 
 
Figure 8: Progression of the SdhD knockdown phenotype using the esg-gal4 driver 
Representative images indicating a progression of the SdhD knockdown phenotype in progenitor cells after 15 
and 30 days of RNAi induction. The number of progenitor cells drastically decreased in the SdhD-RNAi group at 
day 15 (A’) when compared to controls (A; quantified in A’’), reaching eventually zero in most samples at day 30 
(B vs B’; quantified in B’’). In controls, the opposite effect is observed, where the number of GFP-positive cells 
increased (A vs B; quantified in A’’ and B’’, in the plots on the left), which is a normal occurrence during aging. 
Furthermore, the cells in the SdhD-RNAi group at day 15 exhibit morphological changes, such as shrinking. 
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Sample sizes: day 15: n=5 in controls and n=5 in SdhD-RNAi; day 30: n=6 in controls and n=11 in SdhD-RNAi. 
Scale bars = 50 µm. 
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1.2- qRT-PCR quantification confirms downregulation of SdhD 
transcripts upon RNAi expression 
To confirm the effectiveness of the SdhD-RNAi line (ID 101739 KK, VDRC), the levels 
of SdhD mRNA in flies expressing SdhD knockdown versus controls were assessed via 
qRT-PCR (quantitative real-time reverse transcription-polymerase chain reaction). The RNAi 
line was crossed to the EC-specific driver 5966-Gal4GS, the adult flies were left on 
RU/ethanol-containing food for 2 days and whole guts were processed for analysis. This 
specific driver was chosen because ECs comprise most of the cells in the gut, allowing whole-
gut mRNA extractions for quantification. RNAi was induced for 2 days which was considered 
to be enough for RNAi expression and activity, while minimizing other possible phenotypes 
at the intracellular level. 
The housekeeping gene ribosomal protein 49 (RP49) was used as a normalization 
standard, as previously described [51][71][149]. VDRC reports that the 101739 KK RNAi line 
has a theoretical off-target — the PTPMT1 (protein tyrosine phosphatase, mitochondrial 1) 
transcript [132].  For this reason, mRNA levels of this gene were also quantified to determine 
whether unintentional PTPMT1 knockdown occurred. 
qRT-PCR quantification confirmed that mRNA levels of SdhD were lowered in 
intestines of flies expressing SdhD-RNAi to levels about half of the ones in controls (Figure 9, 
bars on the left), showing that the 101739 KK line is effective in knocking down SdhD.  
Levels of the predicted off-target gene PTPMT1, on the other hand, were increased 
upon activation of the RNAi line (Figure 9, black (control) and grey (RNAi) bars to the right), 
showing that the RNAi expression with the 101739 KK line did not lower its levels.  PTPMT1 is 
a protein that localizes to the mitochondria and was previously found to have a role in 
modulating mitochondrial membrane morphology and respiration in mice, as well as 
upregulation of SdhA activity in zebrafish [150][151]. This role of PTPMT1 in upregulating 
SdhA activity could explain why SdhD-RNAi lead to upregulation of this gene. Conceivably, 
suppression of SdhD in ECs could cause a decrease in enzymatic activity of SdhA, as 
previously observed in other systems [152][153], which could induce an increase in PTPMT1 
levels as a response to reestablish SdhA function. These mechanisms were not assessed in 
this study. 
These data indicate that the 101739KK RNAi acts effectively to downregulate the 
levels of SdhD without decreasing the levels of the predicted PTPMT1 transcript. 
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Figure 9: Levels of SdhD and PTPMT1 mRNA upon RNA-interference against SdhD 
Quantification of SdhD levels in whole intestines upon SdhD knockdown in ECs using the 5966
GS
 driver crossed 
to the 101739 KK RNAi line to target SdhD. The levels of SdhD mRNA (bars on the left) are lowered upon SdhD-
RNAi (RU-treated flies; grey bar) when compared to controls (ethanol-treated flies; black bar). The levels of the 
predicted off-target gene PTPMT1 (bars on the right) are strongly increased upon SdhD-RNAi (grey bar) when 
compared to controls (black bar). Values are normalized to RP49  (ribosomal protein 49) transcript levels in 
EtOH controls. Horizontal lines represent SEM. n=3 replicates for each group of 70 intestines. Unpaired two-
tailed Student’s t-test. 
 
Remarks: 
These sections introduced SdhD as a strong candidate required to maintain normal numbers 
of both ISCs and EBs. It was also shown that the esg-gal4 driver induces a stronger 
phenotype than the 5961GS, and that the SdhD-RNAi phenotype when using esg-gal4 is 
progressive, resulting in a total loss of progenitor cells in the region of interest after 30 days. 
These experiments focused on the requirement for SdhD simultaneously in ISCs and EBs and 
did not explore the effects in each cell type individually. In the following chapters, the 
requirements of SdhD for ISCs and EBs separately are covered, using drivers of expression 
specific for each cell type. 
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II – Effects of SdhD knockdown in ISCs and EBs 
2.1- SdhD is required in intestinal stem cells, but not enteroblasts, to 
maintain progenitor cell population 
2.1.1 Knockdown of SdhD specifically in ISCs causes a depletion in the population 
of both ISCs and EBs 
The results presented in the previous sections revealed that knockdown of SdhD in 
progenitor cells (in ISCs and EBs simultaneously) causes a reduction in the population of both 
cell types.  To assess the cell-type specificity of SdhD knockdown, the ISC-specific driver 
esg-Gal4,Su(H)-Gal80,UAS-2xYFP; tub-Gal80TS (described in the Materials and methods 
chapter) was used to knock down SdhD in exclusively ISCs and the resulting abundance of 
both ISCs and EBs was assessed. RNAi expression was activated by shifting the flies from 18 
°C to 29 °C after they reached adulthood — 2-3 days after eclosion — and intestine were 
dissected after 7 days.  
Knockdown of SdhD in ISCs resulted in a significant decrease in their population 
(Figure 10 A, quantified in A’’, in green). To assess the population of EBs in the absence of a 
Su(H)-LacZ reporter in this line, these cells were identified as being YFP-negative (that marks 
only ISCs), Prospero-negative (that marks EEs) and not delimited by the EC-specific 
membrane stain Snakeskin (SSK) [69]. A detailed example of an EB is shown in the A’ insets in 
a control intestine, in an ISC-EB pair where the ISC is marked by YFP (in green) and the EB is 
pointed by the arrow, as a small, Prospero-negative, YFP-negative cell; the SdhD-RNAi 
example shows an ISC-EE pair, where the EE is marked by Pros (in red). Determining the 
abundance of EBs revealed that knockdown of SdhD exclusively in ISCs resulted in a 
significant decrease in the population of EBs (quantified in A’’, in orange). The size of ISCs 
and ECs appear to be increased in SdhD-RNAi flies, which will be discussed in section 2.4.  
These results are in line with the ones described in 1.1 for both progenitor cell types 
and indicate that SdhD is required in ISCs to maintain the abundance of both ISCs and EBs at 
normal levels. At a functional level, possible reasons for progenitor cell depletion include 
reduced division rates, cellular death or forced differentiation to other cell types. In the 
following sections, these parameters are discussed in the context of SdhD knockdown in 
ISCs. In the case of EB loss, a possible explanation is a reduction in the number of ISCs 
leading to failure in replenishing the pool of EBs population via asymmetrical division, while 
existing EBs normally differentiate to either EEs or ECs. In Section III it is confirmed via a 
lineage-tracing experiment that differentiation still occurs upon SDhD knockdown in 
progenitor cells. The following section explores the requirements for SdhD specifically in EBs. 
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Figure 10: Effects of ISC-specific SdhD-knockdown in progenitor cells 
A. Representative images in the midgut upon knockdown of SdhD (lower panels) in ISCs (marked in green (YFP); 
isolated in panels on the right), showing a decrease in their population, when compared to controls (upper 
panels), after 7 days of RNAi expression. EBs were identified as cells that are YFP-negative, Prospero (red)-
negative and are not delimited by the EC-membrane marker Snakeskin (SSK, in orange). An example of an EB is 
pointed by the arrows in upper panels in the insets in A´ (obtained from the red squares in A), in a ISC-EB pair. 
The lower panels (SdhD-RNAi) show an ISC-EE pair (Pros-positive) and no EBs. Scale bars in A = 50 µm. Scale 
bars of insets = 10 µm.  A’’. Abundance of ISCs (in green) and EBs (orange) in control and SdhD-RNAi midguts, 
demonstrating a significant decrease in the population of both cell types upon SdhD knockdown in ISCs. 
Horizontal lines represent mean with SEM. n=10 in controls and n=6 in SdhD-RNAi group. Unpaired two-tailed 
Student’s t-test.  
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2.1.2 Knockdown of SdhD in enteroblasts does not affect their population 
numbers 
In the previous section it was shown that knockdown of SdhD specifically in ISCs 
caused a decrease in the population of both ISCs and EBs, demonstrating a role for ISCs in 
the depletion of the EB population. To assess the effects of SdhD knockdown in EBs, SdhD 
was knocked down specifically in these cells using the driver SuH-Gal4,UAS-GFP; Gal80TS [45]. 
In similarity with the previous experiments, flies were incubated at 18 °C during 
development, and switched to 29 °C 2-3 days after eclosion, to induce RNAi in adult flies.  
Knockdown of SdhD in EBs did not result in a significant difference in the numbers of 
these cells after 6 days of RNAi expression (Figure 11 A; quantified in A’). To assess if a 
longer duration of RNAi expression would elicit a visible phenotype — which in the case 
where the esg-gal4 driver was used resulted in a stronger phenotype (section 1.1, Figure 8) 
— the duration of RNAi expression was extended to 30 days. Once more, RNAi expression for 
30 days did not result in any visible difference between RNAi and controls. At day 30, the 
number of EBs in both control and RNAi groups has increased when compared to day 6 in 
each group, which is expected during aging [56][111].  
These results suggest that SdhD is not required in EBs for maintenance of their 
normal population numbers. One could argue that because EBs are short-lived in 
homeostatic conditions (it takes an EB on average 1 day between forming from an 
asymmetrical division of an ISC and differentiating to either an EE or an EC [72]), the 
expressed RNAi does not have enough time to induce a phenotype and these cells eventually 
differentiate to EEs or ECs, losing their EB identity and RNAi expression. However, in older 
flies such as the ones shown at day 30, is has been shown that EBs present delayed 
differentiation and get ‘stuck’ in an undifferentiated state [54][55][56], which would possibly 
give the RNAi enough time to induce a phenotype in these cells. As future experiments, to 
assess if the lack of a visible SdhD-RNAi phenotype in EBs is not caused by their short state as 
EBs, it is suggested to co-express RNAi against the Sox21a transcription factor, to block their 
differentiation [154] and determine if a longer expression of RNAi elicits a phenotype.  
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Figure 11: Effects of EB-specific SdhD-knockdown in the abundance of EBs 
A. Knocking down SdhD specifically in EBs using the SuH-Gal4,UAS-GFP; Gal80
TS
 driver did not result in a 
significant decrease in the numbers of EBs (marked with GFP), after 6 days (upper panels) or 30 (lower panels) 
of RNAi induction. Scale bars = 50 µm. A’. Quantification of the results represented in the upper panels in A at 
day 6, indicating no significant difference in the number of EBs upon SdhD knockdown in these cells. n=22 in 
the control group and n=20 for SdhD-RNAi. A’’. Quantification of the results exemplified in the lower panels in 
A at day 30. Statistical analysis showed no significant difference between control and SdhD-RNAi groups. n=12 
in the control group and n=8 for SdhD-RNAi. Horizontal lines represent mean with SEM. Unpaired two-tailed 
Student’s t-test. 
 
Remarks 
The results presented in this section show that loss of SdhD in ISCs causes a depletion in the 
population of both ISCs and EBs. On the other hand, EB-specific knockdown of SdhD did not 
produce any discernible phenotype in this cell type, which suggests an ISC-specific 
requirement for SdhD. These data also suggest that the phenotypes previously obtained 
when using the progenitor cell-specific drivers 5961GS and esg-Gal4 (section 1.1) result solely 
from the action of SdhD-RNAi in ISCs, with redundant expression in EBs. The following 
sections aim to characterize the functional aspects leading to loss of ISCs and EBs upon SdhD 
knockdown and possible mechanisms behind it.
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2.2- SdhD is required for normal self-renewal rates in ISCs 
Depletion of progenitor cells following SdhD knockdown as described in the previous 
section may happen due to a variety of factors acting independently or synergistically, such 
as cell death or inability to self-renew. To determine if the depletion of progenitor cells was 
caused by a decrease in self-renewal activity, intestines where SdhD was knocked down in 
progenitor cells using the 5961GS driver (previously used in the screening) were co-stained 
with an antibody against phosphorilated-histone-H3 (pHH3)— a method based on a post-
translational phosphorylation of chromatin that occurs during mitosis [155]— and the 
number of cells undergoing division in each FOV was determined.  
Stained intestines of 8-day-old control flies (no RNAi) revealed a very low frequency 
of cells undergoing mitosis (data not shown), which proved difficult to obtain statistically-
significant data. To overcome this, RNAi and control flies were maintained for 45 days before 
dissections to obtain higher rates of ISC division induced by aging [56].  
Maintaining the flies for 45 days before dissection has resulted in increased rates of 
ISC division in controls (Figure 12, panels on the left). Additionally, the number of ISCs 
undergoing division (pHH3-positive) in aged flies normalized to the total number of ISCs, is 
significantly reduced upon SdhD knockdown (quantified in Figure 12 A). Examples of these 
intestines are shown in Figure 12 B. In the control group (upper panel) an ISC is seen 
undergoing mitosis, marked by pHH3 (orange; pointed by an arrow); insets from the red 
square are shown in B’ where the ISC undergoing division is seen in detail, with condensed 
chromatin (pHH3 and DAPI channels). The lower panels in B show that the number of 
progenitor cells under SdhD-RNAi is not completely depleted, as opposed to the case using 
the esg-Gal4 driver for 30 days. This observation reinforces the idea that the 5961GS driver 
induces lower levels of expression than the esg-Gal4. Furthermore, knockdown of SdhD for 
45 days appeared to reduce the aging-related phenotype of over-proliferation of GFP-
positive cells, and the intestines look similar to the young control ones previously shown 
(Figure 6), suggesting that lower levels of SdhD-RNAi induced by a driver with weaker 
expression might be beneficial to the flies.  
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Figure 12: Effects of SdhD knockdown in the rates of ISC division  
A. Numbers of ISCs undergoing mitosis (pHH3
+
) normalized to the total number of ISCs in the same field of view 
in aged flies, revealing that knockdown of SdhD for 45 days causes a significant decrease in the rate of cell 
division in these cells (light green) compared to controls (dark green). B. Representative images of the data 
shown in A. depicting control (upper panels) vs knockdown of SdhD (lower panels) in progenitor cells (nuclear 
GFP, in green) using the 5961
GS 
driver for 45 days. Enteroblasts are marked by LacZ (red) and the nuclei of all 
cells is marked with DAPI (blue). Cells undergoing mitosis are marked by pHH3 (orange; and panels on the right, 
in greyscale). In this example, an ISC in the control group is undergoing mitosis (pointed by the white arrows). 
Scale bars = 50 µm. B´ Detailed images of the mitotic cell pointed in the red square in B (pHH3-positive) and 
surrounding cells. As expected, pHH3 staining colocalizes with DAPI in the chromatin, that is condensed. Scale 
bars = 5 µm. n=26 in the control group and n=30 in SdhD-RNAi. Unpaired two-tailed Student’s t-test. 
 
The results obtained indicate that SdhD is necessary for normal self-renewal in 
intestinal stem cells, at least in an aging context. These results challenge the general idea 
based on the reports described in the Introduction chapter (3.2), that inhibition of oxidative 
phosphorylation is associated with increased stem cell proliferation. Such observations 
extend to ISCs in Drosophila where knockdown of the mitochondrial pyruvate carrier causes 
decreased respiratory activity and induces proliferation, as described by Schell et al [109], 
suggesting that ISCs cells might be able to fulfill their energetic requirements via anaerobic 
glycolysis. Conversely, other authors have observed an inability of stem cells to progress 
through the cell cycle in the developing eye of Drosophila, and have attributed that to a 
depletion in ATP levels which in turn cause cell cycle arrest via AMPK/p53 elimination of 
cyclin E [118].  Perhaps stem cells in different organs have different metabolic requirements. 
If our ISCs were dividing less due to lack of ATP, one would think that RNAi against other 
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subunits would also cause a similar phenotype, which according to the initial screen, did not 
occur (Figure 5), although this can be attributed to differences in the strength of different 
RNAi lines, or a higher sensitivity of the ATP-generation process in ISCs to loss of SdhD. 
Further experiments should be performed to measure the levels of ATP and O2 consumption, 
as well as lactate production and measurements of anaerobic/aerobic glycolysis.  
The experiments here described with aged flies may not reflect normal homeostatic 
conditions. To overcome the use of phh3 and possibly get a statistical significant number of 
cycling cells in young guts, alternative experiments could include BrdU (5-bromo-2-
deoxyuridine) or EdU (5-ethynyl-2'-deoxyuridine) feeding in young adult flies.  These are 
thymidine analogues are incorporated in DNA during replication in the S phase and can be 
detected using specific antibodies. As these compounds are mixed in the fly food instead of 
used as immuno-labels, they could be incorporated for several days and as such, stain a 
higher number of cycling ISCs. As shown before, higher division rates correlate with higher 
numbers of BrdU-positive ISCs [156]; these assays, however, are less specific than anti-phh3 
as they would also stain cells undergoing endoreduplication [157], rather than only cell 
division. As seen further in section 2.4, these ISCs show signs of endoreduplication which 
could render BrdU/EdU incorporation unfit for assessment of mitotic rates. 
As the apparent reduction in mitosis in ISCs suggests a compromised cell cycle, future 
experiments should include an analysis of the cell cycle progression in these cells. The 
genetically-encoded fly FUCCI (fluorescent ubiquitination-based cell cycle indicator) is a 
valuable tool to assess cell cycle, that is based on fluorophore-tagged degrons from Cyclin B 
and E2F1 proteins that are degraded by the ubiquitin E3-ligases APC/C and CRL4Cdt2, during 
mitosis or at the onset of S phase, respectively. These degrons have attached different types 
of fluorophores (ex.: GFP or RFP), allowing for different phases of the cell cycle to be 
determined [158]. This tool could be co-expressed with SdhD-RNAi and control flies. 
Alternative methods include using anti-Cyclin antibodies to evaluate the cell cycle dynamics 
in these cells and try to pinpoint possible mechanisms resulting in decreased cell division 
rates upon SdhD knockdown. Cyclin D presence would indicate G1 phase, Cyclin E signal 
would indicate G1-S progression, Dacapo expression (an inhibitor of Cyclin E-CDK [159]) 
would show that the cells arrested in G1-S, Cyclin A would indicate S-G2 or G2-M phase 
progression, and Cyclin B would reveal G2-M progression [160].   
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2.3- SdhD is required for ISC survival 
The intestines described in section 2.1 where SdhD-RNAi is expressed specifically in 
ISCs showed some of these cells presenting cytoplasmic rounding and shrinkage, YFP-
positive protrusions and fragments around the cell body (Figure 13 C’), as well as chromatin 
fragmentation (Figure 13 C’’), which were inexistent in controls where ISCs normally present 
a slightly elongated shape and no blebs or chromatin fragmentation (Figure 13 A’, A’’). These 
traits are associated with cell death across different organisms [161][162], including ISCs 
overexpressing the pro-apoptotic genes reaper (rpr) and head involution defective (hid) 
simultaneously [163] that were used as a positive control for apoptotic cells (Figure 13 B’, 
B’’). These data strongly suggest that SdhD-depleted ISCs might be undergoing cell death.  
The cell death-associated protrusions, often named ‘blebs’, are believed to be formed 
by actin-myosin contractions or breaking of the cytoskeleton, causing the cell membrane to 
project outwards. In apoptosis, at later stages, they may contain intact organelles or 
fragments of the cell nucleus, which are enclosed within an intact plasma membrane. These 
protrusions may detach from the cell and be phagocytosed by macrophages and degraded 
within phagolysosomes [161][162][164][165]. In the following paragraphs, I introduce 
different forms of cell death to contextualize the observed phenotypes. 
Apoptosis is a form of programmed cell death that occurs upon intrinsic or 
environmental cues such as cell damage or morphogenesis during development. It is 
characterized by nuclear condensation, DNA cleavage and nuclear fragmentation, loss of cell-
cell contact, rounding of the cell, cell shrinkage due to loss of K+ and water, formation of 
blebs, and cytoplasmic fragmentation into apoptotic bodies [161][162][164][165][166]. At a 
molecular level, apoptosis is initiated by activation of Cysteinyl-aspartases (commonly known 
as caspases) — a type of proteases that contain cysteine in the active proteolytic center and 
are specific for aspartic acid. Caspases and constantly expressed in their inactive form, but 
upon stimuli, are activated to degrade cellular content. Both internal and external stimuli 
may initiate apoptosis. Internal stresses such as DNA damage or endoplasmic reticulum 
stress will initiate the intrinsic pathway which signals to mitochondria causing mitochondrial 
membrane permeabilization, triggering the release of pro-apoptotic factors such as 
Cytochrome c, which indirectly causes proteolytic maturation of caspase 9, an initiator 
caspase. Caspase 9 then cleaves effector caspases such as Caspase 3, Caspase 6 and Caspase 
7, that degrade cellular proteins [167]. In contrast, external stimuli engage the extrinsic 
pathway via activation of death receptors on the cell surface such as the tumor necrosis 
factor-α (TNF) receptor, Fas ligand (FasL or CD95L) receptor or different GPRCs (G protein-
coupled receptors) [168]. Activation of these receptors triggers the assembly of the death-
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inducing signaling complex (DISC) in the cytoplasm which promotes the activation of the 
initiator Caspase 8, which in turn cleaves the aforementioned effector caspases. Caspase 8 
may also activate other effectors such as Bid (H3 interacting-domain death agonist) which 
also causes mitochondrial membrane permeabilization.  
Necrosis, in contrast to apoptosis, is a disorganized, irreversible and uncontrolled 
form of cell death, that occurs upon severe conditions unable to sustain normal physiology. 
These include extreme pH, insufficient ATP or ion imbalance, usually as a consequence of 
conditions such as infection, inflammation, or ischemia. Despite necrosis being traditionally 
thought of as an uncontrollable and  chaotic form of cell death, studies have suggested that 
necrosis is also a regulated process that can be modulated. However, whether active 
signaling pathways for this form of death exist is uncertain. Necrosis is characterized by 
cytoplasmic swelling, early cellular membrane deformation and rupture, spill of cytoplasmic 
content to the extracellular space and cell lysis, swelling and rupture of mitochondria, 
organelle breakdown, accumulation of ROS and intracellular acidification [168][113]. 
Necrosis can be distinguished from apoptosis in that necrotic nuclei do not exhibit 
condensation, fragmentation or DNA cleavage (no DNA-ladder can be detected in a TUNEL 
assay), although DNA degradation occurs in late stages of necrosis [169]. Under very low ATP 
levels, cells programmed to die via apoptosis but unable to do so, may undergo necrosis 
[168]. 
Autophagy is a conserved catabolic process of degradation of cytoplasmic content in 
lysosomes. It is typically a protective, pro-survival response; however, if hyperactivated, it 
leads to cell death. It is a cellular response to a variety of internal and external stress stimuli 
such as nutrient deficiency, hypoxia, ER stress or oxidative stress. Autophagy is critical during 
starvation as self-digestion of non-essential and/or unwanted cellular components, providing 
essential nutrients during periods of stress. Autophagy also serves to remove damaged and 
dysfunctional organelles, misfolded proteins and foreign particles, including microorganisms, 
thus protecting cells against infections. Autophagy itself is not a form of cell death, but 
excessive autophagy may trigger cell death via apoptosis or necrosis [166]. Autophagy can 
facilitate apoptosis by maintaining ATP levels during starvation to promote ATP-dependent 
apoptotic processes such as formation of membrane blebs [168]. 
Cells can also die by a process called Caspase-independent cell death (CICD), that is 
defined as death occurring from pro-apoptotic signaling that leads to mitochondrial 
membrane permeabilization but fails to activate caspases. This may occur from damage 
induced by overwhelming generation of ROS, often by damaged mitochondria [168]. When 
induced by external stimuli, it is normally termed necroptosis. CICD is associated with partial 
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chromatin condensation, nuclear shrinking, abundancy of autophagosomes, but unlike 
apoptosis, no DNA laddering or formation of membrane blebs occurs [170]. 
In ‘blebbing’ SdhD-depleted ISCs, their compacted cytoplasm suggests that they may 
not be undergoing necrosis, since necrotic cells are usually swollen. Furthermore, necrotic 
ISCs shown in the study from Hou et al. do not appear to display blebs [113]. As cells dying 
by CICD cells do not display blebs, this form of cell death can perhaps be also ruled out. As 
SdhD-RNAi cells presented blebs, fragmented chromatin, and a shrunk, round cytoplasm, it 
suggests that they were undergoing apoptosis. 
To test if SdhD-depleted ISCs were undergoing apoptosis, several detection assays 
were tested in intestines expressing SdhD-RNAi in ISCs and in intestines expressing rpr and 
hid, as a positive control for apoptotic ISCs. Intestines of UAS-rpr,UAS-hid flies displayed a 
reduced population of intestinal stem cells after 1 day of RNAi in adult flies. Unfortunately, 
immunofluorescent assays using antibodies against cleaved caspase 3 failed to detect 
apoptotic cells both in positive controls (rpr,hid) and SdhD-RNAi intestines (data not shown). 
The TUNEL assay (described in the Materials and methods chapter) was also used to look for 
fragmented DNA, but also failed to detect apoptosis in rpr,hid and SdhD-RNAi flies. The 
genetically-encoded Apoliner reporter that contains a caspase-sensitive site that upon 
cleavage initiates a fluorescent signal [171] was used in equivalent conditions but also failed 
to detect apoptosis in rpr,hid ISCs. It is not clear why these assays did not work in the 
intestine. Other researchers have also reported not being able to detect apoptosis in positive 
controls in the intestine of Drosophila ([172]; personal communications), although a recent 
report shows successful detection of apoptosis in ISCs in the intestine of Drosopila using anti-
Cleaved Caspase 3 antibodies [173].  
 
67 
 
 
Figure 13:  ISCs depleted of SdhD show hallmarks of cell death 
SdhD knockdown (C) at day 13 causes ISCs to display phenotypes similar to those commonly observed during 
cellular death such as blebs and fragments around their main body, rounding of the cell (C’ inset) and apparent 
nuclear fragmentation (C’’; pointed by the arrow). These traits are also visible in positive-control apoptotic ISCs 
expressing the pro-apoptotic genes rpr and hid (B; B’; B’’), but not present in controls (A; A’; A’’). The nucleus of 
the cell shown in C’’ seems to be separating into two parts, similarly to the one in B’’. Scale bars = 50 µm. Scale 
bars of insets = 5 µm. 
 
Suggested future experiments to confirm cell death in ISCs include the use of the 
fluorescent agent propidium iodide (PI) that stains necrotic cells, as these cells are unable to 
maintain an impermeable membrane and allow PI to infiltrate and stain RNA and DNA 
[174][113]. pGFP-Atg8a, a Drosophila reporter of autophagy would indicate the levels of 
autophagy in each cell [175]. Another test would be to use antibodies against cell death 
markers other than cleaved caspase 3, such as other caspases, bid, or cytochrome C. Co-
expression of the anti-apoptotic gene p35 would rescue cell death if ISCs were dying by 
apoptosis, as previously observed in intestinal progenitor cells of Drosophila [148]. 
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Electron microscopy (EM) is a powerful tool to indicate the state of the cell in respect 
to the different types of cell death. EM images show cell membrane integrity, mitochondrial 
membranes, chromatin and nuclear membrane, autophagosomes and autolysomes. During 
apoptosis, blebs with intact organelles could also be visualized by EM, while mitochondria 
would be damaged in necrosis. Excess autophagy would show several autophagosomes, as 
double-membraned vesicles that contain intact organelles [167]. 
As mitochondria are important modulators of apoptotic pathways (release of pro-, 
and anti-apoptotic factors), autophagy (under low ATP levels) and necrosis (due to 
generation of reactive oxygen species (ROS), but also under low ATP levels), it is not entirely 
surprising that knockdown of genes involved in metabolism induces cell death. Accordingly, 
previous studies have demonstrated that metabolic impairment leads to apoptosis, necrosis 
or autophagy [176][177], via inhibition of growth factors or unknown mechanisms. 
These observations strongly suggest that SdhD-RNAi ISCs undergo cell death, which 
might contribute to the reduced population of ISCs observed upon SdhD knockdown in 
previous sections. It is unclear if ISCs undergo cell death due to general shutdown of cellular 
functions induced by SdhD knockdown, or if there is a specific pathway activated upon SdhD 
knockdown that triggers cell death. Both cases are discussed further later. 
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2.4- Loss of SdhD triggers hypertrophy in intestinal stem cells 
Knockdown of SdhD specifically in ISCs using the driver esg-Gal4,Su(H)-Gal80,UAS-
2xYFP; tub-Gal80TS as described in the previous sections caused a drastic increase in the size 
of ISCs after 7 days (Figure 14 A). These cells display a visibly larger cytoplasmic size and 
increased nuclei area and apparent DNA content — obtained indirectly by integrating the 
fluorescent DAPI signal over the nucleus area, as previously described [1][131] (quantified in 
Figure 14 B; pointed out by arrows in A, lower right panel, vs controls, upper right panel). 
The cytoplasm of enlarged ISCs extends as a thin layer overlapping the membranes of ECs 
(stained with SSK, in orange), suggesting that these cells are growing basally through the 
space left between ECs, and thus maintain their basal ISC identity (Figure 14, lower left 
panel).    
These observations suggest that SdhD-depleted ISCs undergo a 
hypertrophic/endoreduplication program. Endoreduplication, also referred as endocycling, 
occurs during normal development or in adult organisms in specific cell types. An increase in 
DNA content allows higher rates of gene expression, helping build larger cells, which can be 
advantageous in cases in which disruptions of the cytoskeleton or cell adhesion via mitosis 
would compromise tissue barrier function. This is the case of ECs in the Drosophila midgut, 
which can go up to 4 rounds of endoreduplication [158][50]. To achieve polyploidy, cells 
enter G1 and S phases. but skip different parts of the cell cycle, namely mitosis, depending 
on the cell type [50] (Figure 15; details in caption). Cellular hypertrophy refers to abnormal 
cell size commonly occurring as an adaptive response, and is usually accompanied by 
endoreduplication, although not all polyploid cells are necessarily considered hypertrophic 
[178][179].  
To initiate endocycling, the cell cycle must be altered to skip mitosis while still 
allowing progression through G1 phase and DNA replication during S phase. G1 phase is 
necessary to assemble pre-replication complexes (PreRCs), which are used during S phase for 
proper DNA replication. To bypass mitosis, M-CDK (mitotic CDK; the cyclin-dependent kinase 
that drives G2-to-M phase progression) is downregulated, while S phase CDK (S-CDK; 
activated by expression of Cyclin E to drive G1-to-S progression) is periodically inactivated to 
allow the transition into G1 or G2 phase. In Drosophila, Notch signaling plays a major role in 
switching from a mitotic to an endocycle during differentiation in the midgut and follicle cells 
in the ovary [50]. Activation of Notch via Delta initiates a series of cascades that timely 
repress M-CDK, inhibiting mitosis, and promote entering G1 phase to allow formation of 
PreRCs and S phase for DNA replication [180].  
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Figure 14: Knockdown of SdhD causes hypertrophy in ISCs 
A. Knockdown of SdhD (lower panels) vs control (upper panels) in ISCs for 7 days. Knockdown of SdhD causes 
ISCs (YFP-positive) to become hypertrophic, evidenced by a clear increase in their cytoplasmic and nuclei size 
(pointed by the arrows in the panels on the right in both control and SdhD-RNAi). The overlap between the 
cytoplasm of ISCs and EC-membrane stain Snakeskin (SSK, in orange, lower left panel) suggests these cells are 
growing basally in the space left between the ECs. The size of ECs also appears increased in the SdhD-RNAi 
group. Scale bars = 50 µm. B. Quantification of nuclei area and DNA content in ISCs. Nuclei area was 
significantly increased in the SdhD-RNAi group, as represented in the plots on the left. The DNA content in the 
nuclei of ISCs was indirectly quantified by integrating the DAPI intensity over the area of each nuclei, revealing 
a significant increase in the SdhD-RNAi group, shown in the plots on the right, in arbitrary units. n=10 intestines 
in the control group and n=6 in SdhD-RNAi. Unpaired two-tailed Student’s t-test. 
 
 
Figure 15: Cell cycle abbreviations in different cell types 
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To achieve polyploidy, cells must proceed through G1 and S phases but skip mitosis (M phase), or at least 
cytokinesis. As depicted in this diagram, different polyploid cells go through the cell cycle skipping different 
parts, as indicated by the thin arrows. Drosophila salivary glands (SGs) skip the heterochromatin replication 
part of the S phase and re-initiate the cycle proceeding through G1. Mouse trophoblast giant cells (TGCs) and 
Arabidopsis thaliana cells complete the S phase and briefly enter G2 to then proceed through G1.  Mouse 
megakaryocytes (MKCs) go through G2 and initiate mitosis but exit before telophase (Telo) and re-enter G1, a 
variant called endomitosis.   Mouse hepatocytes (HPCs) proceed through a normal cycle but skip only 
cytokinesis, a cell cycle variant known as acytokinetic mitosis, which produces multi-nucleated cells.  Source: B. 
Edgar et al. [50]. 
 
Common pathways associated with hypertrophic growth/polyploidy during 
homeostasis or upon stress are the IGF pathway, with downstream effectors PI3K, AKT, 
FOXO, RAS and TOR [181][182][50]; c-Jun N-terminal kinase (JNK)-dependent Yorkie 
activation [182][183]; and EGFR/MAPK signaling [1][50]. In the midgut of Drosophila, 
Amcheslasvksy and colleagues observed that RNAi against tuberous sclerosis complex (TSC) 
in progenitor cells, that normally inhibits the GTPase Rheb and the TOR kinase, causes 
hypertrophy in ISCs. Mutants for TSC had defects in different steps of the cell cycle, and in 
strong similarity with SdhD-depleted ISCs, maintained stem cell identity, had lower division 
rates and were commonly found single instead of paired with another EB, suggesting that 
the population of EBs was also reduced. Feeding rapamycin to TSC-RNAi flies, or co-
expressing TOR-RNAi or a dominant negative form of TOR, rescued the ISC hypertrophy 
phenotype, indicating a role for TOR in this phenotype [184]. Choi and colleagues observed 
that overexpression of insulin receptor in the fly midgut results in abnormally large ECs. 
However, overexpression of InR in progenitor cells did not result in any apparent increase in 
their size, and resulted in increased proliferation [72] as opposed to our results in ISCs, 
suggesting that InR signaling might not play a role in the hypertrophy phenotype in SdhD-
depleted ISCs. At a downstream level, knockdown of genes involved in the regulation of 
mitosis such as cycA (cyclin A) also results  in polyploid ISCs [185], which is consistent with 
the concept that inability to complete mitosis might result in the cells reentering the cell 
cycle, becoming polyploid. 
Polyploidy does not always occur from programmed endocycling — different events 
such as cell fusion, endomitosis, acytokinetic mitosis and mitotic catastrophe also generate 
polypoid cells.  Cell fusion and acytokinetic mitosis—caused by incomplete or no cell plate 
formation, skipping cytokinesis (exemplified in Figure 15 as occurring in mouse 
hepatocytes)—result in multinucleated cells, which was not observed in SdhD-depleted ISCs. 
Endomitosis occurs when a cell enters mitosis but aborts during metaphase or anaphase, 
resulting in several copies of sister chromatids in the nucleus (exemplified in Figure 15 as 
mouse megakaryocytes) [186]. Mitotic catastrophe (MC) occurs when a cell is unable to 
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proceed through mitosis in an unprogrammed manner, resulting in polyploidy; MC is 
discussed in more detail in section 4.2. 
In SdhD-RNAi intestines, the cytoplasmic size of ECs also appears to be increased 
when compared to controls (Figure 14 A; delimited by SSK, in orange). Previous reports in 
different Drosophila and mammalian systems show that cells undergo hypertrophy to 
maintain organ size when mitotic cells are not available to replenish tissue [182]. 
Particularly, Jiang et al. observed that genetically-induced loss of Drosophila intestinal 
progenitor cells causes overall cell loss in the intestine and increased EC size [58]. On the 
other hand, different reports describing progenitor cell loss do not appear to show increased 
EC size [113][148]. It is unclear, however, if the ECs shown here are undergoing a 
hypertrophic program or have simply stretched following a likely loss of ECs due to lack of 
normal ISC function to replace the pool [182].  
In the present case, it is unclear what mechanisms are behind the generation of 
hypertrophic ISCs. It is possible that one of the scenarios described above might result from 
failure to complete mitosis upon SdhD knockdown. To confirm the increase in DNA content 
in ISCs, FACS (fluorescence-activated cell sorting) is suggested as a future experiment 
[50][158]. Alternatively, FISH (Fluorescence in situ hybridization) staining of any specific 
gene, would show how many chromosome copies exist inside the nuclei. Although 
programmed polyploidy is normally an irreversible process and is linked to terminal cell 
differentiation [187], ISCs do not seem to be differentiating, since they still express the 
suppressor of differentiation Esg. The cell-cycle reporter line FUCCI [158] described in section 
2.2 could be used to assess the cell cycle phase in ISCs. A higher percentage of ISCs in S 
phase would be expected when compared to controls, as it is where new DNA is synthesized. 
As alternative, BrdU or EdU incorporation could also be used to mark cells in the S cycle. The 
levels of proteins and transcription factors associated with hypertrophy should be assessed 
to help determine the mechanisms activated upon SdhD knockdown. Knocking down 
effectors of IIS, JNK or EGFR, such as TOR via RNAi could rescue the phenotype. It would 
remain to be determined how knockdown of SdhD led to activation of growth factors. 
Although Notch is not expected to be found in ISCs, because of its role in promoting 
endocycling in differentiating EBs, its levels and downstream mechanisms should also be 
assessed. Live visualization of chromatin dynamics and cell cycle progression expressing a 
fusion of histone 2A with green fluorescent protein [120] is also recommended. In section 
4.4, the role of succinate as a possible trigger to hypertrophy is also explored. 
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III- Effects of progenitor cell-specific SdhD knockdown in 
differentiated cells 
SdhD-RNAi in progenitor cells leads to an increased population of 
enteroendocrine cells 
The requirement for SdhD in progenitor cells for differentiation choices and tissue 
homeostasis was tested by knocking down this gene in progenitor cells using the esg-Gal4 
driver and staining EEs with an anti-Prospero (Pros) antibody, to assess whether loss of SdhD 
leads to changes in the numbers of differentiated cells (EEs and ECs) in the intestine.  
Immunofluorescence images show that SdhD knockdown in progenitor cells led to a 
significant increase in the population of EEs after 6 days (Figure 16 A, A’). The number of ECs 
per field of view, calculated by subracting the number of progenitor (GFP-positive) and 
enteroendocrine (Pros-positive) cells from the total number of cells (DAPI-positive),  remains 
unchanged upon SdhD knockdown in progenitor cells (Figure 16 A, A’).  
 These results suggest a that differentiation bias towards an enteroendocrine fate 
occurs upon SdhD knockdown in progenitor cells. To confirm these results, lineage-tracing 
was assessed using the esg-FlipOut tool [58][131] (esg-Gal4,tub-Gal80TS,UAS-GFP; UAS-
flp,act>CD2>Gal4; described in the Materials and Methods chapter). Expression of this 
construct in progenitor cells for 5 days revealed a slight differentiation preference towards 
EEs in the SdhD-RNAi group (B, lower panels, EE progeny is marked by both Pros and GFP, 
pointed by arrows), compared to controls where differentiation occurs mostly towards ECs 
(B, upper panels, large GFP-positive cells), although quantification of these occurrences 
showed no significant difference (B’). Experiments with a large sample size should be 
repeated to obtain more robust results.  
The observed phenotypes are consistent with a loss of notch signaling in EBs [38][45], 
which is required at higher levels for differentiation into ECs. The loss of normal function in 
ISCs described in the previous chapters could lead to a depletion in the levels of Delta which 
in turn would result in lower Notch signaling in EBs. To test this hypothesis, it is 
recommended as a future experiment to express the Notch intracellular domain (Nintra)  in 
EBs while expressing SdhD-RNAi in ISCs, to evaluate if it would rescue the phenotype. To 
confirm loss of Delta, anti-Delta antibodies should be used to co-stain these guts. 
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These data showed that loss of SdhD does not affect the capacity of EBs to 
differentiate, although they do not differentiate normally. It is unclear if the observed effect 
happens in ISCs or EBs as the esg-Gal4 driver expresses Gal4 in both cell types.  
 
Figure 16: Effects of SdhD knockdown in differentiation choices 
A. Images showing an increase in the numbers of EEs (marked by anti-Prospero, in red; isolated in the panels on 
the right) after 6 days of SdhD-RNAi in progenitor cells (lower panels) when compared to controls (upper 
panels). A’. Quantification of the number of EEs and ECs upon SdhD knockdown in progenitor cells, showing a 
significant increase in the number of EEs upon SdhD knockdown and no significant difference in the number of 
ECs. n=24 in controls and n=30 in the SdhD-RNAi group. B. Lineage tracing analysis in progenitor cells at day 5 
using the esg-FlipOut tool, that marks progenitor cells and their lineage (EEs / ECs) with GFP (in green). In the 
controls (upper panels) it is shown that all progenitor cells differentiated into ECs (large, GFP-positive cells), 
while on the SdhD-RNAi group there are several marked EE progeny (small, GFP-positive, Pros-positive (red) 
cells) B’. Quantification of the results represented in B, indicating a preference for EE fate over ECs in SdhD-
RNAi individuals when compared to controls, although not statistically significant.  n=8 in controls and n=5 in 
the SdhD-RNAi group.  Scale bars = 50 µm.
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IV- Mechanisms of action 
In this section, I explore possible mechanisms of action mediating ISC death and hypertrophy 
upon SdhD knockdown, via experimental approaches and previously published results.  
4.1- No evidence of ROS accumulation upon SdhD knockdown 
Reactive oxygen species (ROS) play an important role in stem cell behavior. While 
high or uncontrolled levels of ROS may damage lipids, protein and DNA leading to cell death, 
homeostatic levels of ROS are required for proper stem cell function and proliferation 
[98][188][189].  
The mitochondrial electron transport chain is a significant generator of ROS, including 
complex II [190], and SDH deficiencies are associated with elevated ROS levels within the cell 
[191]. To test if SdhD knockdown elicited an increase in ROS levels, the oxidative state in the 
mitochondria of SdhD-knockdown progenitor cells was assessed using the ROS-sensitive 
mito-roGFP reporter. 
4.1.1 The mito-roGFP reporter reveals no changes in the oxidative state in 
mitochondria of SdhD-knockdown cells 
The mito-roGFP reporter (described in the Materials and Methods chapter) was used 
to quantify the ratio of oxidative/reductive potential within the mitochondria of SdhD-RNAi 
and control progenitor cells. The SdhD-RNAi and pKC43 control lines were crossed to a line 
containing the 5961GS driver promoting the expression of the mito-roGFP construct in 
progenitor cells. The flies were raised in normal food and 2-3 after eclosion, both groups 
were switched to RU-containing food to activate mito-roGFP expression, and the 
oxidative/reductive state in the mitochondria of these cells was assessed at day 8.  
This experiment showed that no changes in the oxidative/reductive state of the 
modified GFP protein appear to occur, suggesting that mitochondria in progenitor cells 
depleted of SdhD are not in a more oxidative or reduced state than the ones in the control 
group (Figure 17). This experiment, however, was limited to the fact that ISCs were not 
distinguished from EBs, and as such the results refer to the oxidative state in mitochondria of 
both cell types, which could be different for both. To overcome this, it is suggested to add a 
Su(H)-LacZ reporter and co-stain samples with anti-β-Gal antibodies in the red channel to 
discard EBs in the analysis. Suggested future experiments include using the oxidant-sensitive 
dye dihydroethidium (DHE) that indicates intracellular ROS levels [113]. 
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Figure 17: Analysis of the oxidative environment in mitochondria using the mito-roGFP probe 
A. Quantification of the fluorescence-based redox indicator mito-roGFP showing that expression of SdhD-RNAi 
does not result in a significant change in the oxidative potential in the mitochondria of progenitor cells. Each 
circle/square represents the average ratio per intestine, obtained by integrating the mito-roGFP signal from 10 
cells of each intestine. n=9 individuals in the control group (pKC43; in red) and n=9 in SdhD-RNAi (101739 KK; in 
orange). Unpaired two-tailed Student’s t-test.  B. Fluorescence images showing the mito-roGFP signal in 
mitochondria of progenitor cells. Oxidized probe (Oxi) in blue and middle panels. Fluorescent signal from 
probes in the reduced state (Red) in yellow and right panels.  Cell membranes are marked with anti-Armadillo 
(red) and EEs marked with anti-Prospero (red; not shown). Scale bars = 5 µm.  
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4.1.2 Knockdown of ROS-scavenger Superoxide dismutase 2 does not replicate 
SdhD knockdown phenotypes 
Superoxide dismutase 2 (SOD2) is a conserved ROS scavenger enzyme localized in the 
mitochondria that has an important role in preventing accumulation of ROS originating from 
the ETC [192]. Knockdown of SOD2 in Drosophila has been shown to lead to increased 
endogenous oxidative stress and reduced lifespan [193].  
To test if SOD2 depletion in progenitor cells would replicate the SdhD-knockdown 
phenotypes, SOD2 was knocked down in these cells by means of RNAi using the esg-Gal4 
driver. The w1118 line was used as control to match the genetic background of the UAS-SOD2-
RNAi line. As seen in Figure 18, the progenitor cell population has increased slightly, 
although not significantly. Consistent with these findings, previous reports show that ROS 
are necessary for ISC replication in Drosophila and increased levels lead to a higher ISC 
population [194]. This SOD2-RNAi line was previously used successfully reducing SOD2 levels 
and causing phenotypes resulting from ROS accumulation [192][195]. 
 
Figure 18: Effects of SOD2-RNAi in the abundance of intestinal progenitor cells 
A. Immuno-fluorescent images comparing the effects of RNAi targeting the ROS-scavenger SOD2 (Superoxide 
dismutase 2) in progenitor cells (GFP
+
) in controls (left) vs RNAi (right). Scale bars = 50 µm. B. Quantification of 
the results represented in A, showing that SOD2-RNAi does elicits only a small, non-significant change in the 
number of progenitor cells. n=10 in controls and n=5 in SdhD-RNAi. Unpaired two-tailed Student’s t-test. 
Remarks: 
The data presented in this section together with previous reports suggest that ROS are not 
responsible for the phenotypes observed upon SdhD knockdown. While mutations in 
complex II genes are commonly associated with elevated ROS levels, other mechanisms 
resulting from SdhD knockdown might overcome the proliferative response normally caused 
by increased ROS levels.  In the following sections, data is presented to elucidate other 
possible mechanisms elicited by SdhD knockdown in ISCs. 
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4.2- Mitotic catastrophe 
Mitotic catastrophe (MC) is defined as inappropriate entry or progression through 
mitosis, resulting in polyploidy or cell death [196]. It may originate from chemical or physical 
stress or ionizing radiation, causing DNA damage and defective cell cycle checkpoints. It has 
also been associated with inhibition of complex I of the ETC [197]. MC is characterized by 
changes in nuclear morphology, polyploidy, cell fusion and often results in giant cells 
containing multiple micronuclei [198]. Rather than a form of cell death, MC is a trigger that 
often results in cell death via apoptosis, necrosis or CICD  [169]. Although most cells die 
following MC, there is evidence that a small fraction of cells can survive this event 
[198][199]. Surviving cells can become senescent or stay viable, polyploid cells, which may or 
may not divide again generating daughter cells with different nuclei size [175]. Cell 
senescence is characterized by cell cycle arrest in the G1 phase and in some cases is 
associated with cellular hypertrophy [199][200]. Senescent ISCs, however, do not show 
increased cell size or polyploidy [111]. Moreover, SdhD-RNAi ISCs becoming polyploid is an 
indication that they are not arrested in the cell cycle.   
Although SdhD-depleted ISCs share with MC cells such as polyploidy and cell death, 
they seem to lack other hallmarks such as the heterogenous nuclei signature or 
multinucleated cells. The nuclei of SdhD-RNAi ISCs (Figure 13), seem more homogeneous 
than the ones described following MC, also visualized via IF [198], suggesting that they are 
fragmenting as part of cell death instead of forming the micronuclei normally observed in 
MC. To test if the cells undergo MC, it is suggested as future experiment to obtain EM 
images where the nuclear membrane and chromatin are clearly shown to rule out the 
existence of these traits. Furthermore, the use of live imaging could provide clues as to the 
chromatin dynamics during the cell cycle. These experiments should be complemented by 
cell cycle analysis, to determine if the ISCs show signs of entering mitosis, namely by the 
presence of Cyclin B.  
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4.3- The importance of the enzymatic activity of succinate 
dehydrogenase  
The results presented in the previous sections show that the knockdown of the 
subunit D of mitochondrial complex II of the respiratory chain in progenitor cells leads to a 
depletion in the population of these cells. In the initial screening presented in section I, the 
subunit C of complex II, SdhC, presented a similar phenotype, albeit less intense. The 
similarity in phenotypes resulting from knockdown of both complex II subunits C and D 
suggests that the results previously presented might be complex II-specific and possibly, 
resulting from a downregulation of its enzymatic activity.  
RNAi-targeting Complex II Subunit A in progenitor cells with the esg-Gal4 driver 
phenocopies Subunit D knockdown  
The enzymatic activity of complex II is provided by SdhA. To test if a knockdown of 
SdhA in progenitor cells elicits an equivalent phenotype as the one observed with the SdhD-
RNAi using the esg-Gal4 driver, SdhA was knocked down in equivalent conditions. 
Knockdown of SdhA using the esg-Gal4 driver for 6 days has resulted in a significant 
depletion in the population of progenitor cells (Figure 19), similar to the phenotype caused 
by knockdown of SdhD in section 1.1 (Figure 7). These results strongly suggest that the 
phenotypes presented in sections 1 and 2 may be complex II-specific. Knockdown of SdhA 
with the 5961GS driver in the initial screen did not result in a significant phenotype, which is 
attributed to a weaker activity of this driver when compared to esg-Gal4 [45][147]. The 
differences between SdhA and SdhD in the screening could be explained by a weaker RNAi 
activity of the former. 
Given that the observed phenotypes appear to be complex II-specific role in the 
depletion of progenitor cells upon RNAi, and complex II is also part of the Krebs cycle, a side 
experiment was performed to knockdown isocitrate dehydrogenase (Idh) — a component of 
the Krebs cycle that converts isocitrate to α-ketoglutarate. Upon Idh knockdown for 6 days 
using the esg-Gal4 driver there was no observed phenotype (Supplemental Figure 
2),suggesting that this Krebs cycle enzyme is not required at normal levels in progenitor cells. 
Previous reports have shown that ablation of different subunits of complex II cause a 
decrease in the enzymatic activity of complex II (SDH). In humans, a specific mutation in 
SdhD causes a decrease in the enzymatic activity of SDH [153], while SdhA mutations cause 
the same effect in humans and yeast [152], as well as SdhB mutations in flies [191]. These 
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data suggest that knockdown of SdhD in ISCs might be related to decreased activity of SDH in 
these cells.  
 
Figure 19: Effects of SdhA knockdown in intestinal progenitor cells 
A. Knockdown of subunit A of complex II (right panel) replicated the phenotype of subunit D (SdHD) 
knockdown, in terms of reducing in the number of progenitor cells (green, GFP-positive) when compared to 
pKC43 controls (left panel). Accordingly, there also appears to be less progenitor cell pairs in the RNAi group. 
Scale bars = 50 µm. B. Quantification of progenitor cell numbers shows a significant decrease in the abundance 
of these cells upon SdhA-RNAi, replicating the SdhD-RNAi results. n=13 in the control group and n=8 in SdhA-
RNAi. Statistics: unpaired two-tailed Student’s t-test. 
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4.4– Succinate as a driver of hypertrophy and cellular death 
The previous sectionss showed that a downregulation of subunits of complex II 
causes a reduction in the number of progenitor cells, suggesting a complex II-specific 
mechanism. Impaired enzymatic SDH activity caused by knockdown of complex II 
components has been shown to inhibit the conversion of succinate to fumarate in the Krebs 
cycle leading to accumulation of succinate [201][202][203]. Besides its role as a citric acid 
cycle intermediate, succinate also has a signaling function where it activates the cell-
membrane G-protein-coupled-receptor GPR91 [204]. GPR91 has been shown to activate Gq 
protein signaling [205], which is involved in hypertrophy and cellular death via apoptosis 
[206][207][208][209][210].  
Succinate is transported through the inner mitochondrial membrane via the 
mitochondrial dicarboxylate carrier (DIC) (encoded by the SLC25A10 gene (solute carrier 
family 25 member 10) in humans [211]) and Dic1 (CG8790) in Drosophila [212]. It is then 
transported across the outer mitochondrial membrane by the voltage-dependent anion 
channel VDAC [213], Porin in Drosophila [214]. Finally, it is transported extra-cellularly via 
sodium-dicarboxylate cotransporters, specifically SLC13A3 in mammals [215] and INDY in 
Drosophila [216][217]. These transporters are not specific for succinate and also transport 
small molecules and other Krebs cycle intermediates and dicarboxylates, such as pyruvate, 
fumarate, malate and citrate [217][218][219]. 
G-protein-coupled-receptors (GPCRs) are a group of transmembrane proteins that 
are conserved across species and exist in a variety of cell types with specific roles. These 
receptors are coupled to a heterodimer of G proteins (guanine nucleotide–binding 
regulatory proteins) consisting of subunits α, β and γ.  When inactive, subunit α is bound to 
GDP; upon binding of an agonist to the receptor, an allosteric change takes place in the 
complex causing GDP to leave and be replaced by GTP, which in turn causes disassociation of 
subunit α from the other two subunits and allows it to target its effector molecules. Alpha 
subunits have several forms with distinct roles, the main ones being Gs, Gi, Gq and Gt [220].  
Since the discovery in 2004 of succinate as a ligand for GPR91, this receptor has been 
extensively studied. GPR91, encoded by SUCNR1, in mammals is expressed in the kidney, 
liver, spleen, intestine, adipose tissue and cardiomyocytes [204][221][222][223]. 
Experiments using a library of 800 compounds and 200 carboxylic acids revealed that GPR91 
binds exclusively with succinate; while succinate does not bind with any of the 30 other 
tested GPCRs [204]. Depending on the cell type, the GPR91 receptor associates with 
Gs, Gi or Gq alpha subunits, triggering a variety of signaling pathways [205][224].  
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Previous reports show that overexpression of Gq in cultured cardiomyocytes leads to 
hypertrophy and apoptosis depending on its expression levels: overexpression of Gq (4-fold 
normal levels) causeded hypertrophy while higher expression (8-fold) caused hypertrophy 
followed by apoptosis. This progression from hypertrophy to apoptosis was accompanied 
with activation of p38 and JNK MAPKs [225].  Other researchers have reported that succinate 
feeding in rats enhances the amount of artificially induced ventricular hypertrophy via 
PI3K/AKT signaling upon GPR91 activation [226].  Aguiar et al observed that administration 
of succinate to rats activates GPR91 in cardiomyocytes, causing hypertrophy via extracellular 
signal-regulated kinase 1/2 (ERK1/2), expression of calcium/calmodulin dependent protein 
kinase IIδ (CaMKIIδ) and translocation of histone deacetylase 5 (HDAC5) into the cytoplasm 
[227]. Furthermore, activation of GPR91 has also been associated with modulation of JNK 
signaling [228].    
Succinate may also trigger other effects independent of GPR91 activation. 
Knockdown of SDHA in mice results in accumulation of succinate that competes with the 
Krebs Cycle intermediate α-ketoglutarate (α-KG) to inhibit α-KG-dependent dioxygenases—
conserved enzymes that catalyze reactions on a diverse set of substrates, such as proteins, 
DNA/RNA and lipids.  This leads to a cascade of events resulting in genome-wide histone 
methylations [203][229]. Further gene expression studies need to be performed to obtain a 
detailed map of the gene modulation arising from increased succinate. Mutations in complex 
II subunits in humans have been shown to lead to benign tumors that express high levels of 
succinate. It is though that these tumors arise from succinate-mediated hypermethylation of 
histones and DNA [230].  
Succinate also inhibits prolyl hydroxylases (PHDs), stabilizing Hif1-α [153][201]. As 
such, high concentrations of succinate mimic the hypoxic state and induce the transcription 
of Hif1-α-dependent genes, that include genes involved cell survival or conversely, apoptosis 
[231].  
In summary, succinate accumulation can trigger a variety of cellular events, either 
through GPR91 activation or other mechanisms such as epigenetic modulation or Hif1-α-
mediated transcription of a variety of genes. Given the relation between mutations in 
complex II and increased succinate levels, we speculated that knockdown of SdhD would also 
increase the levels of succinate, which could have a possible role in inducing hypertrophy 
and death in ISCs. As such, the levels of succinate upon SdhD knockdown were quantified. 
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4.4.1- Knockdown of SdhD causes an accumulation of succinate 
To test our hypothesis that SdhD knockdown in flies causes an increase in the levels 
of succinate, RNAi was delivered in adults flies for 13 days using the ubiquitous driver tub-
Gal4; Gal80TS, crossed to the 101739KK SdhD-RNAi line or pKC43 control. Extracts from 
whole individuals were then analyzed using gas chromatography tandem mass spectrometry 
(GC-MS) to detect and quantify the levels of succinate.  
GC-MS analysis showed that knockdown of SdhD in whole flies resulted in a marked 
increase in the levels of succinate (Figure 20; corresponding chromatograms and mass 
spectra in Supplemental Figure 3).  These data demonstrate that ubiquitous knockdown of 
SdhD (and possibly other subunits of complex II) causes an accumulation of succinate, likely 
originating from impaired SdhA activity in the conversion of succinate to fumarate.  
To explore a possible role of succinate as an GPR ligand in Drosophila, the NCBI Gene 
database [232] was used to look for GPR91 homologues. Despite GRP91 being conserved 
across a number of mammals and chicken and frog, there is, no homolog reported for 
Drosophila melanogaster.  To look for possible homologues with a similar sequence, a Basic 
Local Alignment Search Tool (BLAST) [233] query of human SUCNR1 (accession number 
NP_149039.2) over the Drosophila proteome was performed to find potential succinate 
receptors in the fly, which resulted in several alignments (Supplemental Table 1). The 
protein that produced the highest score is one of unknown function (accession number 
ABO52826.1), while others are known G protein-coupled receptors for allatostatins — a  
type of neuropeptide hormone commonly found in insects. The ABO52826.1 protein scored 
an identity of 26% over 84% of the sequence (‘query cover’), with an E value of 1.00E-19. 
Query cover refers to the percentage of the sequence that was selected for its similarity to 
be analyzed; the E value corresponds to the number of alignments expected by chance (the 
lower this value, the more significant is the correspondence); Identity corresponds to the 
percentage of matches in the alignment. As comparison, the Lgr2 receptor in Drosophila 
(NP_476702.1), the homolog of the mammalian ISC marker Lgr5 (NP_003658.1 in humans) 
[234][235] generated an identity of 29% over 44% of the sequence with an E value of 1e-115 
[233]. Overall, the Drosophila genome contains ∼200 genes coding for (putative) GPCRs 
related to hormones, neurotransmitters, olfactory and taste receptors, of which several 
remain orphan [236].   
Future work should include knocking down the succinate transporters Dic1, VDAC 
(aka porin, CG6647) or INDY (CG3979) while co-expressing SdhD-RNAi in the same cells, to 
observe if it rescues the phenotype. These experiments should be carefully controlled since 
these transporters are not specific for succinate and its knockdown could lead to effects 
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related to deficient transport of other metabolites such as citrate or malate, or even 
succinate playing other roles.  Pharmacological inhibitors targeting the succinate 
transporters have the disadvantage of not being specific to ISCs.  
Further experiments should be performed to test if any of the GPR candidates acts as 
a succinate receptor. The levels of activated G proteins in ISCs isolated by FACS could 
indicate if these were activated via GPR signaling upon SdhD knockdown. Alternatively, it is 
suggested to knockdown SdhD simultaneously with each of the candidate proteins.  If a 
candidate protein has a role as succinate receptor to induce hypertrophy and cell death, 
these phenotypes would be rescued in a loss-of-function background. The same principle 
could be applied to G proteins, although given the ubiquitous nature of these proteins, one 
would expect undesired effects in ISCs from its action upon activation from other receptors.  
The authors of the original study that revealed GPR91 as a succinate receptor, 
hypothesized that the carboxyl groups (-COOH) in succinate were responsible for its agonist 
effect in GPR91. As these groups are negatively charged at biological pH, they should bind to 
positive amino acid residues on GPR91. After identifying possible amino acids, the 
researchers used mutagenesis to identify Arg 99, His 103, Arg 252 and Arg 281 as being 
required for GPR91 activation by succinate, while mutations of other amino acids where not 
required for activation. A comparison of about 300 GPCRs revealed that GPR91 uniquely 
contains all four basic residues [204].  These same principles could be used to select 
candidate proteins as succinate receptors in the fruit fly. 
To test the role of succinate in the observed phenotypes, another suggested 
experiment is to feed succinate to the flies. In similarity with RU, succinic acid is soluble in 
ethanol [237] and could be added to the fly meal. It is unclear if succinate would be able to 
reach ISCs without being metabolized before. 
In conclusion, it was shown that ubiquitous knockdown of SdhD increases the levels 
of succinate in flies, which could elicit the phenotypes described in sections 1 and 2. These 
data refers only to accumulation of succinate in whole flies, and the effects on ISCs were not 
specifically tested. To assess the levels of succinate specifically in ISCs, fluorescence-
activated cell sorting (FACS)  of ISCs is recommended to separate these cells.   
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Figure 20: Levels of succinate in whole flies upon ubiquitous SdhD knockdown 
Ubiquitous knockdown of SdhD resulted in an accumulation of succinate in whole flies (orange bar), when 
compared to controls (blue) after 13 days of RNAi expression, as quantified by GC-MS (details in Supplemental 
Figure 3). SdhD-RNAi (VDRC 101739 KK) was expressed in whole flies using the tub-gal4 driver. As control, the 
pKC43 line was crossed to the same driver line. 3 biological replicates were used for each group, with 15 flies in 
each. Statistics: Unpaired two-tailed Student’s t-test; p = 0.0233. 
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General Discussion 
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Characterization of the SdhD-RNAi phenotype in progenitor cells 
In this work, we performed a screen to explore the requirement for subunits of 
different ETC complexes in intestinal progenitor cells (ISCs and EBs) of Drosophila. Different 
subunits were individually knocked down via RNAi in intestinal progenitor cells of adult flies 
using the progenitor cell — and temporal — specific driver 5961GS. SdhD and SdhC of 
complex II emerged as strong candidates revealing both a similar phenotype in which the 
abundance of progenitor cells in the tissue was reduced (Figure 5). Knockdown of complex II 
subunit A (SdhA) did not result in a significant phenotype, but using the stronger esg-Gal4 
driver resulted in a significant decrease in the number of progenitor cells in the intestine, in 
similarity with SdhC and SdhD, which is attributed to a stronger expression of the esg-Gal4 
driver (see section 4.3). These results suggest a complex II-specific requirement in intestinal 
progenitor cells. Further experiments showed that knockdown of SdhD specifically in ISCs 
causes a significant reduction in the number of both ISCs and EBs, while EB-specific 
knockdown of SdhD did not result in changes in the abundance of these cells, indicating an 
ISC-specific requirement for SdhD (section 2.1). In addition, it was determined that ISCs 
depleted of SdhD display reduced rates of division (section 2.2). ISCs depleted of SdhD also 
display visible signs of cell death, such as cytoplasmic blebbing, shrinking and chromatin 
fragmentation (section 2.3). Further analysis showed that SdhD-depleted ISCs undergo 
hypertrophy, exhibiting a larger cytoplasmic and nuclear size, and higher nuclear content 
(2.4), suggesting that these cells become polyploid, which is a trait normally restricted to ECs 
or late EBs that are differentiating to ECs. To achieve polyploidy, cell must skip mitosis (or at 
least, cytokinesis) [50], which might explain the reduction in the rates of division observed in 
2.2. 
Additionally, preliminary data suggest that SdhD is required in progenitor cells for 
normal differentiation choices, as cells depleted of SdhD appear to present a differentiation 
bias towards an EE fate instead of EC, which is implied by an increased number of EEs upon 
SdhD knockdown in progenitor cells and an apparent increase in the numbers of EE-marked 
progeny observed in a lineage-tracing experiment, while the abundance of EC-marked 
progeny decreases (section 3). The differentiation bias towards an EE fate could be explained 
by lack of Delta-Notch signaling. As Notch signaling in EBs is dependent on the Delta ligand 
produced in ISCs, the loss (or malfunction) of ISCs could lead to a decreased Notch signaling 
in EBs, leading to a preference in differentiation towards EEs. Further experiments need to 
be performed to detect Delta and Notch levels in ISCs and EBs. 
The phenotypes resulting from loss of SdhD in progenitor cells appear to occur in a 
progressive manner: during the first 6 days, most EBs are lost and fewer ISCs remain (see 
 90 
 
section 1.1), after which ISCs become larger (more noticeable at days 7 and 13; see sections 
2.3 and 2.4), and continue to disappear, likely through cell death (2.3), until complete 
depletion at day 30 (section 1.1, Figure 8). In light of the results obtained in sections 1, 2 and 
3, the observed loss of EBs is attributed to differentiation of these cells into EEs and ECs 
(section 3), coupled to reduced division rates and death of ISCs (2.2 and 2.3), limiting their 
ability to generate EBs via asymmetric division. The loss of ISCs is attributed to cell death, as 
discussed in 2.3. The use of different drivers revealed the importance of the strength of GAL4 
expression in generating the obtained phenotypes. SdhD knockdown in progenitor cells 
using the 5961GS driver in flies fed 10 µg/ml RU did not result in hypertrophic ISCs that were 
seen using the ISC-specific driver based on esg-Gal4, neither a strong, cumulative reduction 
in their numbers, as visible in Figure 12 where they still maintain a reasonable 
representation in the intestine after 45 days of SdhD-RNAi expression. 
Mechanisms behind hypertrophy and cell death in intestinal stem cells 
Many of the pathways that promote cell growth and polyploidy, such as the 
PI3K/AKT/TOR pathway, inhibit autophagy and apoptosis [176]. Accordingly, the authors 
who previously reported hypertrophy in ISCs via TOR activation, did not report cellular death 
[184]. This suggests that the observed results do not result from a typical 
hypertrophy/growth program, or that there are different mechanisms working in parallel 
that ultimately result in cell death. Despite many of the pathways that promote cell growth 
and polyploidy being associated with cell survival, two known processes are associated with 
polyploidy and cell death: mitotic catastrophe and succinate signaling via its receptor, GPR91 
in mammals.  
The observation of polyploidy and cell death in ISCs depleted of SdhD may indicate 
that these cells are unable to proceed through mitosis and become polyploid in a process 
named mitotic catastrophe (MC), which usually leads to cell death (described in 4.2). In this 
scenario, cells unable to proceed to mitosis would either die, or reenter the interphase of 
the cell cycle, increasing their DNA content and cell size. This hypothesis is in line with the 
observed results in that ISCs depleted of SdhD divide less (as seen in section 2.2) in the 
absence of a complete mitotic process, become polyploid and larger (2.4) and eventually die 
(2.3). It and also accounts for the specificity of the phenotype in ISCs and its absence in EBs 
(2.1), since it occurs from mitosis, which in principle does not occur in EBs. However, this 
does not account for the complex II specificity, since RNAi for subunits in other complexes 
did not elicit such phenotype, although this could be explained by differences in 
effectiveness of RNAi constructs or sensitivity of the OXPHOS process to loss of complex II 
components. If ISCs are very sensitive to loss of complex II subunits, perhaps they would not 
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have available energy to proceed through mitosis. Conversely, SdhD-RNAi ISCs are growing in 
size and DNA content, which is an energy-required process [82], and suggest a mechanism 
other than reduced ATP. Further experiments need to be performed to test this hypothesis, 
namely performing a complete metabolic profile of SdhD-depleted ISCs, including measuring 
ATP levels and AMPK activation, which occurs under low-energy conditions. 
As knockdown of complex II subunits have been shown in other reports to cause a 
reduction in complex II activity (described in 4.3), leading an in increase in the levels of 
succinate, its levels were assessed in SdhD-depleted flies using the ubiquitous driver tub-
Gal4. This experiment showed that knockdown of SdhD in flies results in an accumulation of 
succinate to levels more than two-fold higher than controls (4.4). The phenotypes of 
hypertrophy and cell death in ISCs could be explained by action of increased levels of 
succinate observed upon SdhD knockdown that trigger pathways responsible for 
hypertrophy and cell death. Previous reports exploring the role of succinate as a signaling 
molecule indicate these possibilities, as described in section 4.4. One possible pathway is the 
activation of the succinate receptor GPR91 that triggers the release of Gq proteins that have 
been previously associated with initiation of hypertrophy and apoptosis. This hypothesis 
accounts for the specificity of complex II observed in the screen, with SdhC-RNAi also causing 
a reduction in the number of progenitor cells (Figure 5) and SdhA-RNAi causing the same 
phenotype with the esg-Gal4 driver (4.3). It does not explain, however, why there was an 
observed effect in ISCs but not in EBs. Perhaps ICSs have receptors that EBs do not have? 
Although the size of ECs around SdhD-depleted ISCs was not quantified, these cells appear to 
be larger than the ones in the control group (Figure 10 A, Figure 14 A). If succinate is 
responsible for increasing the size of ISCs, it could happen that excess succinate produced in 
ISCs could also trigger hypertrophy and cell death in ECs as an extracellular signaling 
molecule. However, the existence of a GPR91 homologue has not yet been confirmed in flies.  
Under the “succinate receptor” hypothesis, it is expected that ISCs are dying by 
apoptosis. Determining the type of cell death in ISCs could provide important clues to the 
mechanisms behind the observed phenotypes, as mitotic catastrophe might result in cell 
death by either apoptosis or necrosis. Interestingly, HiF1-α, which is stabilized by succinate,  
is usually associated with cell survival, inhibiting apoptosis on a transcriptional level. In some 
cases, however, Hif1-α also triggers apoptosis via stabilization of p53 [176].  
Manipulations resulting in reduction of aerobic respiration in ISCs has been shown to 
trigger increased proliferation in these cells [109] — the opposite of the phenotypes 
descibed here — indicating that ISCs should be able to rely on anaerobic respiration for 
survival and proliferation. Perhaps they are able to sustain small reductions in the levels of 
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OXPHOS activity, but not stronger changes. This could explain why SdhA-RNAi using the 
weaker 5961GS driver caused a slight, non-significant, increase in the number of progenitor 
cells (section 1.1), but SdhA-RNAi using the esg-Gal4 driver causes a visible reduction in their 
abundance (4.3). As ISCs rely on beta oxidation [113], it is expected that they require 
OXPHOS to some level, since Acetyl-CoA resulting from beta oxidation must be oxidized in 
the mitochondria for energy production.  
It remains to be determined if ISCs are skipping mitosis (as strongly suggested from 
the data in 2.2 and 2.4) as part of a program, of simply because they are unable to complete 
it. More experiments are required to dissect the cell cycle dynamics and pathways leading to 
cell death. Live imaging of the midgut [238] would be of great importance in exposing the 
dynamics of the cell cycle in ISCs, namely via observation of chromatin, mitotic spindle and 
nuclear membrane transformations; determination of cyclin/CDK presence and their 
mediators should also be included, as discussed in more detail in section 2.2. EM would 
provide deep insights about the state of organelles such as mitochondria or phagosomes, the 
amount of lipid droplets and the morphology of the chromatin and nuclear membrane, 
giving crucial hints to the type of cell death and metabolic state of the cell [167]. ATP-
depleted cells would likely present several autophagosomes containing organelles 
[167][168]. Finally, the state of pathways normally involved in hypertrophy and survival such 
as IGF, JNK, Hif1-α and Hippo should be assessed; and as described in 4.4, the possible role 
of succinate should be determined. 
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Conclusion 
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The present work aimed at filling a gap in current knowledge regarding how 
individual subunits of the ETC play a role in stem cell behavior. In a knockdown screen in 
intestinal progenitor cells of Drosophila melanogaster with 18 tested ETC subunits, we 
identified subunits of complex II as being required for normal progenitor cell function, whose 
knockdown causes hypertrophy and cell death, a novel phenotype in this system [185], and 
to my knowledge the first report showing a direct cause-effect relation between 
knockdown/mutations in complex II, and cellular hypertrophy and death, although other 
reports have shown a correlation between these [239][240]. These observations also suggest 
a deviation from the current paradigm, in which inhibition of OXPHOS generally leads to 
stem cell proliferation and does not promote cell death [98][99]. 
Furthermore, these findings filled a gap in this field of research regarding the 
requirement for different complexes and subunits of the ETC in progenitor cells, and the 
differences between the ISCs and EBs in Drosophila, as SdhD-RNAi in EBs did not cause any 
discernible phenotype. The results here described also reinforce the importance of 
knockdown strength, cell type, and subunit specificity, for studies based on knockdown of 
metabolic genes. It remains to be exactly determined if in experiments to knockdown 
subunits of the ETC, the results are dependent simply of specific subunits; or the knockdown 
strength, that appears to cause a variety of effects; or the subunit itself having a higher 
importance in the associated complex, and at the end, downregulation of the complex itself 
being responsible for the phenotype.  
Regretfully, there was no opportunity to obtain more insights regarding the mode of 
cell death, changes in the cell cycle, and metabolic state of ISCs. It remains to be determined 
whether the observed phenotypes are part of a hypertrophy/apoptosis program induced by 
succinate; a consequence of unsuccessful mitosis; or other undescribed pathway. 
As ISCs share several similarities with their mammalian counterparts from a 
metabolic perspective [109], future work derived from these experiments might reveal 
conserved pathways important for mammalian ISCs. Strategies for drug development against 
cancer seek targets that affect only cells capable of dividing, such as ISCs but not EBs. Upon 
determination of the exact mechanisms behind the reduction in cell division rates (section 
2.2) and cell death (section 2.3), these could be explored for possible. This study also 
provided a new model for the study of hypertrophy and cell death caused by metabolic 
impairment. Understanding the mechanisms of stem cell proliferation and hypertrophy is 
essential to the fields of regeneration and tissue repair, as both are involved in these 
processes [182]. Further understanding the mechanisms underlying cellular hypertrophy and 
death could support the development of therapies for diseases such as hypertrophic 
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cardiomyopathy — a disease of the myocardium commonly arising from mutations in myosin 
genes with unknown downstream mechanisms, in which cardiomyocytes display increased 
cytoplasmic and nuclear size, higher DNA content [241], and apoptosis [242], and has also 
been associated with mutations in SDHD and complex II defects [239][240].  
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Supplemental Figure 1: Effects of expression from different SdhD-RNAi lines in progenitor cells 
A. Knockdown of SdhD using the 26776GD and 10219R-1  RNAi lines partially replicates the phenotype 
previously obtained with the 101739KK line, with a significant decrease in the number of EBs (LacZ-positive). 
The reduction in the number of ISCs is not significant, which is attributed to a possible weaker RNAi activity of 
these lines. The line w
1118
 was crossed to the esg-gal4 driver and used as control. B. Quantification of the 
number of ISCs and EBs obtained upon SdhD-RNAi with the 26776 GD driver. n=18 in the control group and 
n=21 for RNAi C.  Quantification for the 10219R-1 driver (n=14) vs controls (n=18). Unpaired two tailed 
Student’s t-test. 
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Supplemental Figure 2: Isocitrate dehydrogenase knockdown in intestinal progenitor cells 
A. Quantification of the number of progenitor cells upon knockdown of isocitrate for 6 days reveals only a 
slight, non-significant increase in their numbers. B. Representative images of of Idh-RNAi (right) and control 
intestines (left), not showing any discernable phenotype. Scale bars = 50 µm. n=22 in controls and n=17 in Idh-
RNAi. Statistics: unpaired two-tailed Student’s t-test. 
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Supplemental Figure 3: GC-MS analysis of SdhD-knockdown flies 
A. Chromatogram of pCK43 control extracts showing retention times (RT; x axis) between 9.00 and 19.00 
minutes. In the y axis, ‘abundance’ refers to the absolute number of counts received at the detector which is 
proportional to the amount of each analyte in the sample. The peak at 14.04 min pointed by the arrow 
corresponds to succinate, confirmed by its mass spectrum. A’. Mass spectrum of the succinate 2TMS peak 
(RT=14.04) in controls, covering a molecular mass range of 50 to 265 m/z on the x axis (z corresponds to the 
charge of the particle which is usually +1). These peaks correspond with the ones from empirical data obtained 
from the NIST library (shown in C).  B. Chromatogram of SdhD knockdown flies with the succinate 2TMS peak at 
14.04 min showing a larger area than controls, corresponding to higher abundance of the metabolite. The other 
peaks in the chromatograms A and B correspond mostly to amino acids according to the NIST library (not 
shown) and do not appear to suffer major changes. B’. Mass spectrum of the succinate peak in SdhD-RNAi, 
similar to the one in A´, as expected. C. Empirical mass spectrum of succinate 2TMS obtained from the NIST 
library. The different peaks correspond to the different parts of the molecule that were broken apart, and may 
form new bonds with each other. A small peak is visible at 262 m/z which is the total mass of the derivatized 
succinate molecule.  
Abundance in the mass spectra is relative to the maximum intensity obtained. Arbitrary units in the 
chromatogram reflect absolute abundance of the analytes. 3 biological replicates were used in each group, with 
15 flies in each. 
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Supplemental Table 1: BLAST alignment results of human GPR91 and the Drosophila melanogaster proteome  
Description 
Query 
cover 
E value Ident Accession 
IP03254p 84% 1.00E-19 26% ABO52826.1 
allatostatin C/drostatin C 
receptor 1 
84% 2.00E-19 26% AAL02125.1 
somatostatin receptor  83% 2.00E-19 26% AAK31793.1 
allatostatin C receptor 2, 
isoform D  
83% 2.00E-19 26% NP_001262015.1 
allatostatin C receptor 2, 
isoform B  
83% 2.00E-19 26% NP_649039.4 
allatostatin C receptor 2, 
isoform F 
83% 3.00E-19 26% NP_001303398.1 
G protein-coupled 
neuropeptide pyrokinin-2 
receptor (CG8795) - fruit fly  
86% 2.00E-17 27% JC8012 
putative PRXamide receptor  86% 2.00E-17 27% AAN10043.1 
pyrokinin 2 receptor 2, 
isoform A 
86% 2.00E-17 27% NP_731788.1 
allatostatin A receptor 2, 
isoform B 
91% 2.00E-17 24% NP_001247352.1 
G protein-coupled 
neuropeptide pyrokinin-2 
receptor (CG8784)  
92% 5.00E-17 25% JC8011 
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